Scientific publications from the Scandinavian Sarcoma centers 1998–2003

References

• Jensen ML, Schumacher B, Jensen OM, Nielsen OS, Keller J. Extraskeletal osteosarcomas: a clinicipathological study of 25 cases including immuno- and enzyme (alkaline phosphatase) histochemistry. Am J Surg Pathol 1998; 22: 588–94.
   Google Scholar
• Jensen V. SOrensen FB, Bentzen S, Ladekarl M, Nielsen OS, Keller J, Jensen OM. Prognostic significance of proliferative activity (MI13-1 index) in soft tissue sarcomas. An immu-nohistochemical study including p53 and bc1-2 expression. Histopathology 1998; 32: 536–46.
   Google Scholar
• Johansen R, Nielsen OS, Keller J. Functional outcome in sarco-mas treated with limb salvage or amputation. Sarcoma 1998; 2: 19–23.
   Google Scholar
• Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy A. Randomized trial of single-dose versus fractionated pallia-tive radiotherapy of bone metastases. Radiother Oncol 1998; 16: 233–40.
   Google Scholar
• Nielsen OS, Dombemowsky P. Mouridsen H, Crowther D, Verweij J, Buese J, Steward W, Daugaard S, Van Glabbeke M, Kirckpatrik A, Tursz T. High dose epirubicine is not an to alternative standard dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Br J Cancer 1998; 78(12): 1634–9.
   Google Scholar
• Vraa S, Keller J, Nielsen OS, Sneppen 0, Junk AG, Jensen OM. Prognostic factors in soft-tissue sarcomas: The Aarhus experi-ence. Eur J Cancer 1998; 34: 1876-82.1999
   Google Scholar
• Nielsen OS. Palliative radiotherapy of bone metastasis. There is now evidence for the use of single fractions (editorial). Radio-ther Oncol 1999; 52: 95–6.
   Google Scholar
• Woll PJ, Judson I Lee SM, Rodenhuis S, Nielsen OS, Buesa JM, Lorigan PC, Leyvraz S, Hermans C, van Glabbeke M, Verwiej J. Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 1999; 35(3): 410–2.2000
   Google Scholar
• Bentzen SM, Hoskin P, Ross D Nielsen OS. Fractionated radio-therapy for metastatic bone pain: Evidence-based medicine or? (letter to the editor). Int J Radiat Oncol Biol Phys 2000; 46: 681–3.
   Google Scholar
• Gwyther SJ, Nielsen OS, Judson IR, van Glabbeke M, Verweij J. Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of adult: A study of the EORTC Soft Tissue and Bone Sarcoma Group. Anticancer Drugs 2000; 11:433–7.
   Google Scholar
• Nielsen OS, Dombernowsky P. Mouridsen H, Daugaard S, van Glabbeke M, Kirkpatrick A, Verweij, J. Epirubicin is not supe-rior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group. Sarcoma 2000; 4: 31–5.
   PubMedGoogle Scholar
• Nielsen OS, Judson I, van Hoesel Q, le Cesne A, Keizer HJ, Blay JY, van Oosterom A, Radford JA, Svancarova L, Krzemienecki K, Hermans C, van Glabbeke M, Oosterhuis J. W., Verweij, J.: Effect of high-dose ifosfamide in advanced soft tissue sarco-mas. A multicenter phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2000, 36: 61–7.
   Google Scholar
• SOrensen A, Keller J, Nielsen OS, Jensen OM. Aggressiv fibro-matose. Ugeskr. lxger 2000; 162: 6676–8.
   PubMedGoogle Scholar
• Vraae, S., Keller, J., Nielsen, 0.S., Sneppen, 0., Junk, A.G., Jensen, 0.M.: Prognostiske faktorer ved blOddelssarkomer. Erfaringer fra sarkomcentret i Arhus. Ugeskr. lwger 2000; 162: 931–5.
   Google Scholar
• Vraae S, Keller J, Nielsen OS, Junk AG, Jensen OM. Prognostic factors in 155 patients treated for soft tissue sarcoma of the thigh: The influence of the surgical margin. Acta Orthop Scand 2001; 72: 72–7.
   Google Scholar
• Judson I, Radford JA, Harris M, Blay JY, van Hoesel Q, le Cesne A, van Oosterom A, Verweij J, Kamby C, Hermans C, Donarto di Paola E, Nielsen OS. Randomized phase II trial of pegu-lated liposomal doxorubicin (doxilicaelyx) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma. A study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2001; 37: 870–7.
   Google Scholar
• Nielsen OS. 25th Anniversary Meeting of EORTC STBSG Meet-ing 2001 in Aarhus (introductory comment). Sarcoma 2001; 5: 157184.
   Google Scholar
• Nielsen OS, Horsman M, Overgaard J. A future for hyperthermia in cancer treatment? (editorial comment). Eur J Cancer 2001; 37: 1587–9.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Alsner J, Keller J, Nielsen, OS, Jensen OM, Overgaard J. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br J Cancer 2001; 84: 1070–5.
   Google Scholar
• Van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS. Safety and efficacy of imatinib (5TI571) in metastatic gastrointestinal stromal tumours: A phase I study. Lancet 2001; 358: 1421–3.
   Google Scholar
• di Paola ED, Nielsen OS. The EORTC Soft Tissue and Bone Sar-coma Group. Eur J Cancer Suppl 42002; 38: 138–41.
   Google Scholar
• Nielsen OS, Keller JO, Dombemowsky P. Sarkomer. Ugeskr. Lwger 2002; 164: 3036–9.
   PubMedGoogle Scholar
• Nielsen OS, O'Sullivan B. Retroperitoneal soft tissue sarcomas: A treatment challenge and a call for randomised trials (edito-rial). Radiotherapy 2002; 65: 133–6.
   PubMedGoogle Scholar
• Svancarova L, Blay JY, Judson I, Verweij J, van Hoesel Q, van Oosterom AT, le Cesne A, Keizer HJ, Hermans C, van Glab-beke M, Nielsen OS. Gemcitabine in advanced soft tissue sar-comas of the adult. Phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2002; 38: 556–9.
   Google Scholar
• SOrensen A, Keller J, Nielsen OS, Jensen OM. Treatment of aggressive fibromatosis: A retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand 2002, 73: 213–9.
   PubMed Web of Science ®Google Scholar
• van Glabbeke M, Verweij J, Judson I, Nielsen OS. Progression free rate as the principal end-point for phase II trial on soft tissue sarcoma. Eur J Cancer 2002; 38: 543–9.
   PubMed Web of Science ®Google Scholar
• van Oosterom AT, Judson IR, Verweij J, Stroobants S, Dumez H, Donato di Paola E, Sciot R, Van Glabbeke M, Dimitrijevic S, Nielsen OS. Update of phase I study of imatinib (5TI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Suppl 52002; 38: 83–7.
   Google Scholar
• van Oosterom AT, Mouridsen HT, Nielsen OS, Dombemowsky P. Krzemieniecki K, Judson I, Svancarova L, Spooner D, Her-mans C, van Glabbeke M, Verweij J. Results of randomized studies of the EORTC Soft Tissue and Bone Sarcoma Group with two different ifosfamide regimens in first and second line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer 2002; 38: 2397–406.
   Google Scholar
• Bentzen L, Keiding S, Nordsmark M, Falborg L, Hansen SB, Keller J, Nielsen OS, Overgaard J. Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrods in human soft tissue tumours. Radiother Oncol 2003; 67: 339–44.
   PubMedGoogle Scholar
• Blay JY, van Glabbeke M, Verweij J, van Oosterom AT, Le Cesne A, Oosterhuis JW, Judson I, Nielsen OS. Advanced soft tissue sarcoma: A disease that is potentially curable for a subset of patient treated with chemotherapy. Eur J Cancer 2003; 39: 64–9.
   PubMed Web of Science ®Google Scholar
• Davidsen M, Keller J, JOrgensen PH, Junk AG, Nielsen OS, Jensen OM. Kirurgisk behandling af kwmpecelletumorer i knogle. Ugeskr. Laeger 2003; 165: 3238–42.
   PubMedGoogle Scholar
• Nielsen OS. Ny behandling af sarkomer - et nyt behandlings-gennembrud? Focus pa Krwft og Sygepleje 2003; 2: 9–11. Nielsen OS. Role of systemic treatment in adults soft tissue sarcomas. Eur J Cancer 1 suppl. 2003; 6: 249-59.
   Google Scholar
• Nielsen OS, Blay JY, Judson IR, van Glabbeke M, Verweij J, van Oosterom AT. Metastatic soft tissue sarcomas: Progress and treatment options. A review of the EORTC Soft Tissue and Bone Sarcoma Group. Am J Cancer 2003; 2: 211–21.
   Google Scholar
• Verweij J, van Oosterom A, Blay JY, Judson I, Rodenhuis S, Le Cesne A, Hogendoom P. van Glabbeke M, Dimitrijevic S, Nielsen OS. Imatinib (ST1-571): an active agent for gastro-intestinal stromal tumours, but not yielding responses in other soft tissue sarcomas not selected for molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. Eur J Cancer 2003; 39: 2006–11.
   Google Scholar
• Benassi MS, Ragazzini P. Gamberi G, Sollazzo MR, Molendini L, Ferrari C, Merli M, Böhling T, Picci P. Adhesion molecules in high-grade soft tissue sarcomas: Correlation to clinical out-come. Eur J Cancer 1998; 34: 496–502.
   Google Scholar
• Biscaglia R, Gasbarrini A, Böhling T, Bacchini P. Bertoni F, Picci P. Osteosarcoma of the foot - An easily misdiagnosed malig-nant tumor. Mayo Clinic Proc 1998; 73: 842–7.
   Google Scholar
• Gamberi G, Benassi MS, Böhling T, Ragazzini P. Molendini L, Sollazzo MR, Ferrari C, Magagnoli, G, Balladelli A, Picci P. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology 1998; 55: 556–663.
   Google Scholar
• Gamberi G, Benassi MS, Böhling T, Ragazzini P. Molendini L, Sollazzo MR, Merli M, Ferrari C, Magagnoli G, Bertoni F, Picci P. Prognostic relevance of c-myc gene expression in giant-cell tumor of bone. J Orthopaed Res 1998; 16: 1–7.
   Google Scholar
• Huuhtanen R, Blomqvist C, Wiklund T, Böhling T, Virolainen M, Tribukait B, Andersson L. Expression of cyclin A in soft tissue sarcoma correlates with tumour aggressiveness. Cancer Res 1999; 59, 2885–90.
   Google Scholar
• Huuhtanen RL, Blomqvist CP, Wiklund TA, Böhling TO, Viro-lainen MJ, Tukiainen EJ, Tribukait B, Andersson LA. A com-parison of Ki-67 and S-phase fraction as prognostic variables in soft tissue sarcoma. Br J Cancer 1998; 79: 945–51.
   Google Scholar
• Huuhtanen R, Wiklund T, Blomqvist C, Böhling T, Virolainen, M, Tribukait B, Andersson L. A high proliferation rate meas-ured by cyclin A predicts a favourable chemotherapy response in soft tissue sacoma patients. Br J Cancer 1999; 81, 1017–21.
   Google Scholar
• Kämärdinen M, Miettinen M, Seppald M, von Boguslawsky K,Benassi MS, Böhling T, Andersson LC. Epithelial expres-sion of glycodelin in synovial sarcomas. Int J Cancer 1998, 76: 487–90.
   Google Scholar
• Larramendy ML, Virolainen M, Tukiainen E, Elomaa I, Knuutila S. Chromosome 1q21 is recurrently gained in desmoid tumors. Genes Chromosomes Cancer 1998; 23: 183–6.
   PubMedGoogle Scholar
• Nilbert M, Saeter G, Elomaa I, Monge OR, Alvegfird TA. Ewing's sarcoma treatment in Scandinavia 1984-1990. 10-year results of the Scandinavian Sarcoma Group Protocol SSG IV. Acta Oncol 1998; 37: 375–8.
   Google Scholar
• Skytting B, Bauer H, Perfekt R, Huuhtanen R, Alvegard T, Berlin (:), Gustafson P. Klepp R, Löfvenborg R, Saeter G, Trovik C, Wahlstrom 0. Clinical Course in Synovial Sarcoma: A Scan-dinavian Sarcoma Group Study of 104 Patients. Acta Orthop Scand 998; 70: 536–42.
   Google Scholar
• Szymanksa J, Seim M, Skytting B, Larsson 0, Virolainen M, Akerman M, Tarkkanen M, Huuhtanen R, Picci P. Bacchini P. Asko-Seljavaara S, Elomaa I, Knuutila S. Genetic imbalance in 67 synovial sarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 1998; 23(3): 213–9.
   Google Scholar
• Tarkkanen M, Bohling T, Gamberi G, Ragazzini P. Benassi MS, Kivioja A, Kallio P. Elomaa I, Picci P. Knuutila S. Compara-tive genomic hybridization of low-grade central osteosarcoma. Mod Pathol 1998; 11:421–6.
   Google Scholar
• Tarkkanen M, Huuhtanen R, Virolainen M, Wiklund T, Asko-Seljavaara S, Tukiainen E, Lepäntalo M, Elomaa I, Knuutila S. Comparison of genetic changes in primary sarcomas and their pulmonary metastases. Genes Chromosomes Cancer 1998; 25: 323–31.
   Google Scholar
• Wolf M, Hemminki A, Kivioja A, Sistonen P. Kaitila I, Ervasti H, Kinnunen J, Karaharju E, Knuutila S. A novel splice site mutation of the EXT2 gene in a Finnish hereditary multiple exostoses family. Mutations in brief no.197. Online. Human Mutation 1998; 12(5): 362.
   Google Scholar
• Avizienyte E, Loukola A, Roth S, Hemminki A, Tarkkanen M, Salovaara R, Arola J, Biitzow R, Husgafvel-Pursiainen K, Kokkola A, Järvinen H, Aaltonen L. LKB1 somatic mutations in sporadic tumors. Ara J Path 1999; 154(3): 677–81.
   Google Scholar
• Bauer HC, Alvegard TA, Berlin 0, Erlanson M, Gustafson P. Kivioja A, Klepp R, Lehtinen T, Lindholm P. Moller TR, Ryd-holm A, Saeter G, Trovik CS, Wahlstrom 0, Wiklund T. The Scandinavian Sarcoma Group Register. Acta Orthop Scand Suppl 1999; 285: 41–4.
   Google Scholar
• Ferrari C, Bohling T, Benassi MS, Ferraro A, Gamberi G, Bacci G, Brach del Prever A. Sangiorgi L, Ragazzini P. Sollazzo MR, Balladelli A, Picci P. Secondary tumors in bone sarcomas after treatment with chemotherapy. Cancer Detect Prey 1999; 23: 368–374.
   Google Scholar
• Huuhtanen R, Blomqvist C, Böhling T, Wiklund T, Tukiainen E, Virolainen M, Tribukait B, Andersson LC. Expression of Cyclin A in soft tissue sarcomas correlates with tumor agres-siveness. Cancer Res 1999; 59: 2885–90.
   Google Scholar
• Huuhtanen R, Blomqvist C, Wiklund T, Böhling T, Virolainen M, Tukiainen E, Tribukait B, Andersson LC. A comparison of Ki-67 and S-phase fraction as prognostic varables in soft tissue sarcoma. Br J Cancer 1999; 79: 945–51.
   Google Scholar
• Huuhtanen R, Wiklund T, Blomqvist C, Böhling T, Virolainen M, Tribukait B, Andersson LC. Proliferation measured by Cyclin A predicts chemotherapy response in soft tissue sarcoma patients. Br J Cancer 1999; 81:1017–21.
   Google Scholar
• Larramendy ML, Mandahl N, Mertens F, Blomqvist C, Kivioja A, Karaharju E, Valle J, Böhling T, Tarkkanen M, Rydholm A, Akerman M, Bauer HCF, Anttila JP, Elomaa I, Knuutila S. Clinical significance of genetic imbalances revealed by com-parative genomic hybridization in chondrosarcomas. Hum Pathol 1999; 30(10): 1247–53.
   Google Scholar
• Mania SM, Huuhtanen R, Blomqvist C, Wiklund T, Laurila P. Ristamäki R. Clinical significance of CD44 and CD44v6 in adult soft tissue sarcomas. Br J Cancer, 1999; 84: 224–52.
   Google Scholar
• Popov P. Tukiainen E, Blomqvist C, Huuhtanen R, Virolainen M, Virkkunen P. Asko-Seljavaara S. Soft tissue Sarcomas of the Lower Extremity: Surgical Treatment and Outcome. Eur J Surg Oncol 1999; 26: 679–85.
   Google Scholar
• Ragazzini P. Gamberi G, Benassi MS, Orlando C, Sestini R, Ferrari C, Molendini L, Sollazzo MR, Merli M, Magagnoli G, Bertoni F, Bohling T, Pazzagli M, Picci P. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosar-coma. Cancer Detect Prey 1999; 23: 129–36.
   Google Scholar
• Tarkkanen M, Elomaa I, Blomqvist C, Kivioja A, Bohling T, Kellokumpu-Lehtinen P, Bohling T, Valle J, Knuutila S. DNA sequence copy number increase at 8q - a potential new prognostic marker in osteosarcoma. Int J Cancer 1999; 84(2): 114–21.
   Google Scholar
• Tarkkanen M, Huuhtanen R, Virolainen M, Wiklund T, Asko-Seljavaara S. Tukiainen E, Lepäntalo M, Elomaa I, Knuutila S. Comparison of genetic changes in primary sarcomas and their pulmonary metastases. Genes Chromosomes Cancer 25, 4, August, 1999; 323–31.
   Google Scholar
• Tarkkanen M, Kium-Kuhkfeldt S, Blomqvist C, Armengol G, Bohling T, Ekfors T, Virolainen M, Lindholm P. Monge 0, Picci P. Knuutila S, Elomaa I. Clinical correlations of genetic changes by comperative genomic hybridization in Ewings sarcoma and related tumors. Cancer Gen Cytogenet 1999; 114(1): 35–41.
   Google Scholar
• Wolf M, Tarkkanen M, Hulsebos T, Larramendy M, Forus A, Myklebost 0, Aaltonen L, Elomaa I, Knuutila S. Characteriza-tion of the 17p amplicon in human sarcomas - microsatellite marker analysis. Int J Cancer 1999; 82: 329–33.
   Google Scholar
• Kivioja AH, Wolf M, Ervasti H, Kinnunen J, Kaitila I, Bohling T. Chondrosarcoma in a family with multiple hereditary exosto-ses. J Bone Joint Surg (Br) 2000; 82-B: 261–66, 2000.
   Google Scholar
• Olsson E, Sarlomo-Rikala M, Bohling T, Asko-Seljavaara S, Las-sila R. Immunohistochemical evaluation of failed anastomoses in clinical microsurgery. Br J Plast Surg: 2000; 53: 567–73.
   PubMedGoogle Scholar
• Wolf M, El-Rifai W, Tarkkanen M, Kononen J, Serra M, Eriksen E F, Elomaa I, Kallioniemi A, Kallioniemi 0-P, Knuutila S. Novel findings in gene expression detected in human osteo-sarcoma by cDNA microarray. Cancer Gen Cytogenet 2000; 123: 128–32.
   Google Scholar
• Haila S, Hästbacka J, Bohling T, Karjalainen-Lindsberg ML, Kere J, Saarialho-Kere U. S1c26a2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also other tissues and cell types. J Histochem Cytochem 2001; 49: 973–982.
   PubMedGoogle Scholar
• Joensuu H. Treatment of inoperable gastrointestinal stromal tumor (GIST) with imatinib (Glivec, Gleevec). Med Klin 2001; 96: Suppl II: 1–3.
   Google Scholar
• Joensuu H, Roberts P. Sarlomo-Rikala M, Andersson L, Terva-hartiala P. Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, Demetri G. Clinical response induced by the tyrosine kinase inhibitor S11571 in metastatic gastrointestinal stromal tumor expressing a mutant c-kit proto-oncogene. N Engl J Med 2001; 344: 1052–6.
   Google Scholar
• Kerkeld E, Bohling T, Herva R, Uria J, Saarialho-Kere U. Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant trans-formation. Bone 2001; 29: 487–93.
   Google Scholar
• Olsson E, Svartling N, Asko-Seljavaara S, Lassila R. Activation of coagulation and fibrinolysis in microsurgical reconstruc-tions in lower extremities. Br J Plast Surg 2001; 54: 597–603.
   Google Scholar
• Popov P. Virolainen M, Tukiainen E, Asko-Seljavaara S, Huuhtanen R, Knuuttila S, Tarkkanen M. Primary Soft Tissue Sarcoma and Its Local Recurrence: Genetic Changes Studied by Comparative Genomic Hybridisation. Mod Pathol 2001; 14(10): 978–84.
   Google Scholar
• Serra M, Tarkkanen M, Baldini N, Scotlandi K, Sarti M, Maurici D, Manara MC, Benini S, Bacchini P. Knuutila S, Picci P. Simultaneous paired analysis of DNA content and numerical chromosomal aberrations in osteosarcoma. Mod Pathol 2001; 14(7): 710–6.
   Google Scholar
• Söderström M, Aro H, Ahonen M, Johansson N, Aho A, Ekfors T, Böhling T, Kähäri VM, Vuorio E. Expression of matrix metalloproteinases in human chondrosarcomas. APMIS 2001; 109: 305–15.
   Google Scholar
• Söderström M, Ekfors T, Bohling T, Aho A, Aro HT, Vuorio E.: Cysteine proteinases in chondrosarcoma. Matrix Biol 2001; 19: 717–25.
   PubMed Web of Science ®Google Scholar
• Tarkkanen M, Wiklund TA, Virolainen MJ, Larramendy ML, Mandahl N, Mertens F, Blomqvist CP, Tukiainen EJ, Miet-tinen MMA, Elomaa Al, Knuutila YS. Comparative genomic hybridization of postirradiation sarcomas. Cancer 2001; 92: 1992–8.
   Google Scholar
• Demetri GD, von Mehren M, Blanke CD, van den Abbeele A, Eisenberg B, Roberts PJ, Heinrich, MD, Tuveson D, Singer S, Janicek M., Fletcher JA, Silverman S, Harmon D, Silberman S, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker B, Corless C, Fletcher CDM, Joensuu H. Antitumor effects of an oral selective tyrosine kinase inhibitor, imatinib mesylate, in patients with advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472–80.
   Google Scholar
• Hattinger CM, Pötschger U, Tarkkanen M, Squire J, Zielenska M, Kiuru-Kuhlefelt S, Kager L, Thorner P. Knuutila S, Niggli FK, Ambros PF, Gadner H, Betts DR. Prognostic Impact of Chromosomal Aberrations in Ewing Tumours. Br J Cancer 2002; 86(11):1763–9.
   Google Scholar
• Joensuu H, Dimitrijevic S, Silberman S, Roberts PJ, Demetri GD. Management of gastrointestinal stromal tumours. Lancet Oncol 2002; 3: 655–64.
   Google Scholar
• Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, God-ager LH, South A, Marenholz I, Lioumi M, Florenes VA, Mklandsmo GM, Sena M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland J, Knuutila S, Myldebost 0. Posi-tional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 2002; 21, 2261–9.
   Google Scholar
• Silberman S, Joensuu H. Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: A discus-sion with experts. Eur J Cancer 2002; 38, Suppl 5, S66–S69.
   Google Scholar
• Söderström M, Bohling T, Ekfors T, Nelimarkka L, Aro H, Vuorio E. Molecular profiling of human chondrosarcomas for matrix production and cancer markers. Int J Cancer 2002; 100: 144–51.
   PubMedGoogle Scholar
• Tukiainen E, Saray S, Kuokkanen H, Asko-Seljavaara S. Salvage of major amputation stumps of the lower extremity with latis-simus dorsi free flaps. Scand J Plast Reconstr Surg Hand Surg 2002; 36: 85–90.
   Google Scholar
• van Dartel M, Comelissen PW, Redeker S, Tarkkanen M, Knu-utila S, Hogendoom PC, Westerveld A, Gomes I, Bras J, Hulsebos TJ. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade oste-osarcoma. Cancer Genet Cytogenet 2002; 139(2): 91–6.
   Google Scholar
• Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen C-J, Van den Abbeele, Druker B, Kiese B, Eisenberg B, Roberts P. Singer S, Fletcher CDM, Silberman S, Dimitrijevic S, Fletcher JA. KIT and PDGFRA mutations predict imatinib mesylate response. J Clin Oncol 2003; 21(23): 4342–9.
   Google Scholar
• Smeland S, Muller C, Alvegard TA, Wiklund T, Wiebe T, Bjork 0, Stenwig AE, Willen H, Holmstrom T, Folleras G, Brosjo 0, Kivioja A, Jonsson K, Monge 0, Saeter G. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39(4): 488–94.
   Google Scholar
• TurkuAho AJ, Eskola J, Ekfors T, Manner I, Komi T, Hollrnen T. Immune responses and clinical outcome of massive human osteoarticular allografts. Clin Orthop 1998; Jan (346): 196–206.
   Google Scholar
• Aho AJ, Him M, Aro HT, Heikkild JT, Meurman 0. Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turky Bone Bank 1972–1995. Acta Orthop Scand 1998; 69(6): 559–65.
   Google Scholar
• Laitinen M, Marttinen A, Aho Al, Lindholm TS. Bone momho-genetic protein in bone neoplasms: Comparison of different detection methods. Eur Surg Research 1998; 30: 168–74.
   PubMedGoogle Scholar
• Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C, Armengol G, Bohling T, Ekfors T, Virolainen M, Lindholm P. Monge 0, Picci P. Knuutila S, Elomaa I. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors. Cancer Genet Cytogenet 1999; 114: 35–41.
   Google Scholar
• Parkkola RK, Mattila KT, Heikkild JT, Ekfors TO, Kallajoki M, Komu MES,Vaara T, Aro H. Dynamic contrast-enhanced MR Imaging and MR-guided bone biopsy on a 0.23 T open Imager. Skeletal Radiol 2001; 30: 620–4.
   Google Scholar
• Parkkola R, Mattila K, Heikkild J, Ekfors T, Komu M, Vaara T, Aro H. MR-guided core biopsies of soft tissue tumours on an open 0.23T imager. Acta Radiol 2001; 42: 302–30.
   Google Scholar
• Nilbert M, Swter G, Elomaa I, Monge OR, Wiebe T, Alvegird TA. Ewing's sarcoma treatment in Scandinavia 1984-1990. Acta Oncol 1998; 37(4): 375–8.
   PubMed Web of Science ®Google Scholar
• Trovik CS, Bauer HCF, BrosjO 0, Skoog L, Söderlund V. Fine needle aspiration cytology in the diagnosis of recurrent soft tissue sarcoma. Cytopathology 1998; 9: 320–8.
   Google Scholar
• Bauer HCF, Alvegard TA, Berlin 6, Erlandson M, Gustafson P. Kivioja A, Klepp R, Lehtinen T, Lindholm P. Moller TR, Ryd-holm A, Saeter G, Trovik CS, Wahlström 0, Wiklund T. The Scandinavian Sarcoma Group Register. Acta Orthop Scand 1999; 285(70): 41–4.
   Google Scholar
• Elomaaa I, Blomqvist C, Sater G, Nilbert M, Monge OR, Wiebe T, Alvegard TA. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 69–73.
   Google Scholar
• Femberg JO, Wiklund T, Monge 0, Hall KS, Sater G, Alvegard TA, Strander H. Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 62–8.
   Google Scholar
• Saeter G, Wiebe T, Wiklund T, Monge 0, Wahlqvist Y, Engstrom K, Forestier E, Holmström T, Stenwig AE, Willen H, Brosjo 0, Folleras G, Alvegard TA, Strander H. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 74–82.
   Google Scholar
• Skytting BT, Bauer HC, Perfekt R, Huuhtanen R, Alvegird TA, Berlin 0, Gustafson P. Klepp R, Lofvenberg R, Saeter G, Trovik CS, Wahlstrom 0. Clinical course in synovial sarcoma: A Scandinavian sarcoma group study of 104 patients. Acta Orthop Scand 1999; 70(6): 536–42.
   Google Scholar
• Tarkkanen M, Kiuru-Kuhlefeldt S, Blomqvist C, Armengol G, Milling T, Ekfors T, Virolainen M, Lindholm P. Monge 0, Picci P. Knuutila S, Elomaa I. Clinical correlations of genetic changes by comperative genomic hybridization in Ewings sarcoma and related tumors. Cancer Gen Cytogenet 1999; 114(1): 35–41.
   Google Scholar
• Trovik C, Bauer HCF. Local recurrence after Surgery for Soft Tissue Sarcoma: The Scandinavian Sarcoma Group experi-ence. Acta Orthop Scand 1999; 285(70): 45–6.
   Google Scholar
• Trovik CS, Bauer HCF, Alvegird TA, Anderson H, Blomqvist C, Berlin 6, Gustafson P. Swter G, Wallbe A. Surgical Margins Local Recurrence and Survival in Soft Tissue Sarcoma. Study based on 559 patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000; 36(6): 710–6.
   Google Scholar
• Trovik CS, Gustafson P. Bauer HCF, Swter G, Klepp R, Berlin Erlanson M, Wahlström 0, Raabe N. Consequences of Local Recurrence of Soft Tissue Sarcoma.205 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2000; 71(5): 488–95.
   Google Scholar
• Bauer HCF, Trovik CS, Alvegard TA, Berlin 6, Erlanson M, Gustafson P. Klepp R, Möller TR, Rydholm A, Seeter G, Wahlström 0, Wiklund T. Monitoring Referral and Treatment in Soft Tissue Sarcoma: Study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001; 72 (2): 150–9.
   Google Scholar
• Trovik CS. Local Recurrence of Soft Tissue Sarcoma. A Scan-dinavian Sarcoma Group Project (thesis). Acta Orthop Scand 2001; 72(300): 1–31.
   PubMedGoogle Scholar
• Trovik CS. Patologiske Frakturer. I Einar Sudmann (Red), Kompendium i Frakturbehandling, Bergen 2001 ISBN 82-991471-5–8.
   Google Scholar
• Trovik CS, Bauer HCF, Anderson H, Berlin 6, Tukiainen E, Erlanson M, Gustafson P. Klepp R, Swter G, Wahlström 0. Local recurrence in deep-seated, high-grade, soft tissue sar-coma. 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001; 72(2): 160–6.
   Google Scholar
• Hirth A, Pedersen PH, Baardsen R, Larsen JL, Krossnes BK, Hel-gestad J. Gamma knife radiosurgery in pediatric cerebral and skull base tumors. Med Pediatr Oncol 2003; 40(2): 99–103.
   Google Scholar
• Hirth A, Pedersen PH, Wester K, Mork S, Helgestad J. Cerebral atypical teratoid/rhabdoid tumour of infancy: long-term sur-vival after multimodal treatment, also including triple intrathe-cal chemotherapy and gamma knife radiosurgery - case report. Pediatr Hematol Oncol 2003; 20(4): 327–32.
   Google Scholar
• Smeland S, Muller C, Alvegard TA, Wiklund T, Wiebe T, Bjork 0, Stenwig AE, Willen H, Holmstrom T, Folleras G, Brosjo 0, Kivioja AS, Jonsson K, Monge 0. Saeter G. Scandinavian Sarcoma Group Osteosarcoma Study SSG VEI: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39(4): 488–94.
   Google Scholar
• Wallae A, Trovik C. Kirurgisk behandling av Skjelettmetastaser. Bruk av palliativ kirurgi i behandlingen av kreftpasienter. Senter for Medisinsk Metodevurdering (SMM). SMM-rapport nr 8/2003. SINTEF-Unimed.
   Google Scholar
• Oslo
   Google Scholar
• Aurlien E, Larsen RH, Olsen DR, et al. Selective eradication of micrometastases using 211At-labelled antibodies. In: Towards the Eradication of Osteosarcoma Metastases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 70–1.
   Google Scholar
• Bjamland K, Winberg JO, Odeegaard OT, et al. S100A4 and involvement in metastasis: deregulation of MMP-2 and TIMP-2 in osteosarcoma cells transfected with an anti-S100A4 ribozyme. In: Towards the Eradication of Osteosarcoma Metastases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 126–30.
   Google Scholar
• Bruland OS and PH A. The many faces of osteosarcoma. Some dilemmas and challenges in its current management. In: Towards the Eradication of Osteosarcoma Metastases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 9–15.
   Google Scholar
• Bruland OS, Haifadt H, Breistal, K, et al. Micrometastases in patients with osteosarcoma. Iramunomagnetic detection of tumor cells present in peripheral blood and bone marrow aspi-rates. In: Towards the Eradication of Osteosarcoma Metasta-ses: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 65–6.
   Google Scholar
• El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M. DNA copy number changes in development and progression in leio-myosarcomas of soft tissues. Am J Pathol 1998; 153: 985–90.
   PubMed Web of Science ®Google Scholar
• Forus A, Berner JM, Meza-Zepeda L, et al. Molecular characteri-sation of a novel amplicon at 1q21-q22 frequently observed in human sarcomas. Br J Cancer 1998; 78: 495–503.
   Google Scholar
• Gautvik KM, Rian E, Bruland OS, et al. Human osteosarcoma cells in bone research In: Towards the Eradication of Osteosa-rcoma Metastases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 101–2.
   Google Scholar
• Hassfjell S, Skretting A, Bruland OS, et al. Predicting detect-ability in radioguided surgery: A study based on physical characterization of the probe and on tissue uptake ratios of 1251_, 1535111- and 165Er-labeled radiopharmaceuticals. Nucl Med Communic 1998; 19: 207–17.
   PubMedGoogle Scholar
• Haie J, Skter G, Bruland 0, et al. Selection of patients for thoracotomy-who can be cured by surgery? In: Towards the Eradication of Osteosarcoma Metastases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 62–4.
   Google Scholar
• Kiuru-Kuhlefelt S, El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M. DNA copy number changes in alveolar soft part sarcoma: comparative genomic hybridization study. Mod Pathol 1998; 11: 227–31.
   PubMedGoogle Scholar
• Larsen RH and Bruland OS. Intratumor injection of immuno-globulins labeled with the alpha-emitter 211At: Analyses of tumor retention, microdistribution and growth delay. Br J Cancer 1998: 77 (7): 1115–22.
   Google Scholar
• Larsen RH and Bruland OS. Preliminary evaluation of a new radiolabeled bisphosphonate. J Labelled Compds Radiopharm 1998; 51: 823–30.
   Google Scholar
• Lopes JM, Hannisdal E, Bjerkehagen B, et al. Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers. Anal Cell Pathol 1998; 16: 45–62.
   Google Scholar
• Moe L, Aas M, Gamlem H, et al. Spontaneous osteosarcoma in dogs: clinical experience with targeted radionucleide therapy. In: Towards the Eradication of Osteosarcoma Metastases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 82–6.
   Google Scholar
• Nilbert M, Skter G, Elomaa I, et al. Ewing's sarcoma treatment in Scandinavia 1984-1990. Ten-year results of the Scandina-vian Sarcoma Group protocol SSG IV. Acta Oncol 1998; 37: 375–8.
   Google Scholar
• Nordal RR, Kristensen GB, Stenwig AE, et al. Immunohisto-chemical analysis of p53 protein in uterine sarcomas. Gynecol Oncol 1998; 70: 45–8.
   PubMed Web of Science ®Google Scholar
• Nordal RR. Uterine sarcomas in Norway 1956–1992. An epide-miological and clinicopathological study. Thesis. University of Oslo, 1998.
   Google Scholar
• Olsen DR and Bruland OS. Radiotherapy in Scandinavia. Acta Oncol 1998; 37 (6): 553–60.
   Google Scholar
• Olsen DR and Bruland OS. Is osteosarcoma a radioresistant tumor? In: Towards the Eradication of Osteosarcoma Metas-tases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 73–6. Skter G, Bruland OS. High-grade osteosarcoma (OS): the scope beyond the "classical" patient. In: Towards the Eradication of Osteosarcoma Metastases: an Odyssey, ISBN 82-91929-02-5, Oslo 1998: 21–3.
   Google Scholar
• Aas M, Moe L, Gamkm H, Skretting A, Bruland OS. Internal radionuclide therapy in dogs with primary osteosarcoma employing 153Sm-EDTMP. Clin Cancer Res 1999; 5: 3148–52.
   Google Scholar
• Alvegird TA, Bauer H, Blomqvist C, Mailer T, Rydholm A, Skter G. The Scandinavian Sarcoma Group. Background, organization and the Central Register - the first 20 years. Acta Orthop Scand Suppl 285 1999; 70: 3–7.
   Google Scholar
• Bauer HCF, Alvegird TA, Berlin 6, Erlanson M, Gustafson P. Kivioja A, Klepp R, Lehtinen T, Lindholm P. Moller TR, Rydholra A, Skter G, Trovik C, Wahlstrom 0 and Wiklund T. The Sarcoma Group Register. Acta Orthop Scand Suppl 285 1999; 70: 41–4.
   Google Scholar
• Bemer JM, Salk T, Mertens F, Henriksen J, Skter G, Mandahl N, Bragger A, Myklebost 0, Lothe R. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumours from patients with neurofibromatosis type 1. Stuydies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer 1999; 26: 151–60.
   Google Scholar
• Bjerkehagen B, Dietrich C, Reed W, Micci F, Skter G, Berner AA, Nesland JM, Heim S. Extraskeletal myxoid chondrosar-coma: multimodal diagnosis and identification of a new cyto-genetic subgroup charaterized by t(9;17)(q22;q11). Virchows Archiv 1999; 435: 524–30.
   PubMedGoogle Scholar
• Elomaa I, Blomqvist C, Skter G, Nilbert M, Monge 0, Wiebe T, Alvegard TA. Chemotherapy in Ewing's sarcoma. The Scandi-navian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 69–73.
   Google Scholar
• Femberg JO, Wiklund T, Monge 0, Sundby Hall K, Skter G, Alvegard TA, Strander H. Chemotherapy in soft tissue sar-coma. Acta Orthop Scand Suppl 285 1999; 70: 62–8.
   Google Scholar
• Holmstram T, Bohling T, Akerman M, Willén, Stenwig AT, Bertoni E Diagnosis and tumor response in ostesarcoma and Ewings's sarcoma, according to treatment protocols SSG II, SSG VIII, ISG/SSG I, SSG IV and SSG IX. Acta Ortop Scand Suppl 285 1999; 70: 27–9.
   Google Scholar
• Jemtland R, Rian E, Olstad OK, Haug E, Bruland OS, Bucht E, Gautvik KM. Two human osteoblast-like osteosarcoma cell lines show distinct expresion and differential regulation of parathyroid hormone-related protein. J Bone and Mineral Res 1999; 14: 904–14.
   Google Scholar
• Larse RH, Bruland OS, Zalutsky. Radioimmunotherapy of osteo-sarcoma. Future prospects. In Riva P. ed.: "Cancer therapy with monoclonal antibodies", Harwood Ac Publ, ISBN90-5702-309-1, Amsterdam 1999: 209–29.
   Google Scholar
• Larsen RH, Mumd KM, Akabani G, Hoff P. Bruland OS, Zalutsky MR. 211m_ and 1311-labeled bisphosphonates with high in vivo stability and bone accumulation. J Nucl Med 1999; 40: 1197–1203.
   PubMed Web of Science ®Google Scholar
• Meis-Kindblom JM, Bjerkehagen B, BOhling T, Domanski H, Halvorsen TB, Larsson 0, Linen& P. Myhre-Jensen 0, Stenwig E, Virolainen M, Willén H, Akerman M,Kindblom LG. Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register; The peer-review committee experience. Acta Orthop Scand Suppl 285 1999; 70: 50–7.
   Google Scholar
• Micci F, Teixeira MR, Dietrich CU, Swter G, Bjerkehagen B, Heim S. Combined RxFISH/G-banding allows refined karyo-typing of solid tumors. Human Genetics 1999; 104: 370–5.
   PubMed Web of Science ®Google Scholar
• Olafsen T, Munthe Lund CK, Bruland OS, Sandlie I, Michaelsen TE. Complement mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 anti-bodies. Cancer Immuno. Immunther 1999; 75: 755–83.
   Google Scholar
• Panagoupoulos I, Mencinger M, Dietrich CU, Bjerkehagen B, Saeter G, Mertens F, Mandahl N, Heim S. Fusion of RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11). Oncogene 1999; 18(52): 7594–8.
   PubMedGoogle Scholar
• Pedeutour F, Forus A, Coindre JM, Berner J-M, Nicolo G, Mich-iels J-F, Terrier P. Bailly C, Collin F, Myklebost 0, Turc-Carel C. Structure of ring and giant rod marker chromosomes in adipose tissue tumors: A study combining fluorescent in situ hybridization, comparative genomic hybridization, molecular analyses and immunohistochemistry. Genes Chromosomes Cancer 1999; 24: 30–41.
   Google Scholar
• Rydholm A, Gustafson P. Alvegird TA, Swter G, Blomqvist C. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 50–7.
   Google Scholar
• Simons A, Schepens M, Forus A, Godager L, van Asseldonk M, Myklebost 0, van Kessel AG. A novel chromosomal region of allelic loss, 4q32-q34, in human osteosarcomas revealed by representational difference analysis. Genes Chromosomes Cancer 1999; 26: 115–124.
   Google Scholar
• Skytting BT, Szymanska J, Aalto Y, Lushnikova T, Blomqvist C, Elomaa I, Larsson 0, Knuutila S. Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization. Cancer Genet Cytogenet 1999; 115: 39–46.
   Google Scholar
• Swter G, Wiebe T, Wiklund T, Monge 0, Wahlqvist Y, Engstrom K, Forestier E, Holmstrom T, Stenwig AE, Willén H, Brosjo 0, Folleris G, Alvegfird TA, Strander H. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 74–82.
   Google Scholar
• Winderen M, Stenwig AE, Solheim OP, Saeter G, Aas M. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients. Acta Ortop Scand Suppl 285 1999; 70: 11–7.
   Google Scholar
• Wolf M, Tarkkanen M, Hulsebos T, Larramendy ML, Forus A, Myklebost 0, Aaltonen LA, Elomaa I & Knuutila S. Charac-terization of the 17p amplicon inhuman sarcomas - microsatel-lite marker analysis. Int J Cancer 1999; 82: 329–33.
   Google Scholar
• Aurlien A, Larsen RH, Olsen DR, Bruland OS. Alpha-par-ticle radioimmunotherapy versus external beam irradiation of human osteosarcoma and bone marrow: Analyses of microdo-simetry and cell survivial. Int J Radiat Biol Phys 2000; 76(8): 1129–41.
   Google Scholar
• Bauer HCF, Trovik C, Alvegird TA, Berlin 6, Erlanson M, Gustafson P. Klepp R, Moller TR, Rydholm A, Sxter G, Wahlström 0, Wiklund T. Monitoring referral and treatment in soft tissue sarcoma: Study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2000; 72: 150–9.
   Google Scholar
• Brekken C, Bruland OS, de L Davis C. Interstitial fluid pressure in human osteosarcoma xenografts: Significance of implanta-tion site and the response to intratumoral injection of hyal-uronidase. Anticancer Res 2000; 20(5), 3503–12.
   Google Scholar
• Brekken C, Hjelstuen MU, Bruland OS and de L Davis C. Hyal-uronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteo-sarcoma xenografts. Anticancer Res 2000; 20(5): 3513–19. Bruland OS, Nil A. Targeted radiotherapy in the treatment of osteosarcoma. Radiobiological basis, clinical status, and future prospects. In Abrams P and Fritzberg A eds "Radioimmuno-therapy of Cancer". Marcel Dekker Inc. ISBNO-8247-0277-8. New York 2000: 323–37.
   Google Scholar
• Bruland OS. Sarkomer — Kreft i binde og stOttevev. Kreftsykep-leie — Pasient, Utfordring, Handling. ISBN 82-7950-018-9. Reitan AM and Schjølberg TK (eds) 2000: 447–52.
   Google Scholar
• Elomaa I, Blomqvist CP, Saeter G, Akerman M, Stenwig E, Wiebe T, Bjork 0, Alvegard TA. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma group experience with the SSG IX protocol. Eur J Cancer 2000; 36(7): 875-80. Kiuru-Kuhlefelt S, Sarlomo-Rikala M, Larramendy ML, Soderlund M, Hedman K, Miettinen M, Knuutila S. FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma. Mod Pathol 2000; 13: 433–7.
   Google Scholar
• Knuutila S. Sytogenetiikka ja molekyylipatologia syöpätautien diagnostiikassa - esimerkkeind lymfoomat ja sarkoomat. Suom Lääkäril 2000; 17: 1831–41.
   Google Scholar
• Lushnikova T, Knuutila S, Miettinen M. DNA copy number changes in epithelioid sarcoma and its variants: a comparative genomic hybridization study. Mod Pathol 2000; 13: 1092-6. Mertens F, Larramendy M, Gustavsson A, Gisselsson D, Rydholm A, Brosjo 0, Mitelman F, Knuutila S, Mandahl N. Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p. Cancer Genet Cytogenet 2000; 116: 89–96.
   Google Scholar
• Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V. Molenaar I, van der Berg E, Myklebust 0, Bridge J, van Kessel AG and Suijkerbuijk R. Frequent loss of 9p21 (p16INK4A) and other genomic imbal-ances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 2000; 118(2): 89–98.
   Google Scholar
• Sirvent N, Forus A, Lescaut W, Burel F, Benzaken S, Chazal M, Bourgeon A, Vermeesch JR, Myklebost 0, Turc-Carel C, Ayraud N, Coindre JM, Pedeutour F. Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer 2000; 29: 117–29.
   PubMed Web of Science ®Google Scholar
• Skjeldal S, Lillis F, Folleris G, Stenwig AS, Sarnset E, Tillung T, Fosse E. Real time MRI-guided excision and cryo-treatment of osteoid osteoma in os ischii - a case report. Acta Orthop Scand 2000; 71(6): 637–8.
   PubMed Web of Science ®Google Scholar
• Trovik C, Bauer HCF, Anderson H, Berlin 6, Tukiainen E, Erlanson M, Gustafson P. Klepp R, Sxter G and Wahlström 0. Local recurrence in deep-stated high-grade soft tissue sarcoma. 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2000; 72: 160–6.
   Google Scholar
• Trovik C, Gustafson P. Bauer HCF, Swter G, Klepp R, Berling 6, Erlanson M, Wahlström, Raabe N. Consequences of local recurrence of soft tissue sarcoma. 205 patients from the Scan-dinavian Sarcoma Group Register. Acta Orthop Scand 2000; 71: 488–95.
   Google Scholar
• Trovik CS, Bauer HCF, Alvegird T, Anderson H, Blomqvist C, Berlin 6, Gustafson P. Swter G, WallOe A. Surgical margins, local recurrence and metastasis in soft tissue sarcoma; 559 sur-gically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000; 36(6): 710–6.
   Google Scholar
• Bauer HCF, Trovik CS, Alvegird TA, Berlin 6, Erlanson M, Gustafson P. Klepp R, Moller TR, Rydholm A, Swter G, Wahlström 0, Wiklund T. Monitoring referral and treatment in soft tissue sarcoma: Study based on 1851 patients from the Scandinavian Sarcoma Group Register, Acta Orthop Scand, 2001; 72: 150–9.
   PubMed Web of Science ®Google Scholar
• Fodstad 0, HOifödt HK, Faye R, Bruland OS, Holstad L, Aamdal S. Irmnunomagnetic detection of micrometastatic cells in bone marrow predicts survival of patients with malignant melanoma and osteosarcoma. Proc Am Assoc Cancer Res, 2001: 1542.
   Google Scholar
• Forus A, Bjerkehagen B, Sirvent N, Meza-Zepeda LA, Coindre J-M, Berner J-M, Myldebost 0, Pedeutour E A new type of chromosome 12-derived markers found in a well-differenti-ated Liposarcoma. Cancer Genet Cytogenet 2001; 131: 13–8.
   PubMedGoogle Scholar
• Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Florenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, Del Vecchio Blanco F, Muller C, Sanvito F, Kononen J, Nesland JM, Fodstad 0, Reymond A, Kallioniemi OP, Anig-goni G, Ballabio A, Myklebost 0, Zollo M. Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nrn23-H1 activity. Oncogene 2001; 20: 6881–90.
   Google Scholar
• Forus A, Larramendy ML, Meza-Zepeda LA, Bjerkehagen B, Godager L, Dahlberg AB, Smter G, Knuutila S, Myklebust 0. Dedifferention of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Cancer Genet Cytogenet 2001; 125: 100–11.
   Google Scholar
• Hassfjell S, Ingebrigtsen K, Bruland OS. Synthesis, purification and biodistribution of 205Bi-DOTMP, visualizing bone deposi-tion patterns with autoradiography. Nucl Med Biol 2001; 28: 425–33.
   Google Scholar
• Hauser M. Rib biopsy using CT-guidance: concept, technique, and instrumentation. Radiology 2001; 221(P): 666.
   Google Scholar
• Hauser M, Lloret I, Skjeldal S. Upper and lower extremity compartmental anatomy in the planning of CT-guided mus-culoskeletal biopsies: a pictorial review. Radiology 2001; 221(P): 661.
   Google Scholar
• Hovig E, Myklebost 0, Aamdal S, Smeland EB. Genterapi ved kreft. Tidskr NorLmgefor 2001; 121(4): 482–8.
   PubMedGoogle Scholar
• Kiuru-Kuhlefelt S, El-Rifai W, Fanburg-Smith J, Kere J, Miet-tinen M, Knuutila S. Concomitant DNA copy number ampli-fication at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 2001; 92: 192–5.
   PubMedGoogle Scholar
• Kvirmsland Y, Skretting A, Bruland OS. Radionuclide therapy with bone-seeking radiopharmaceuticals: Monte Carlo cal-culations of dose-volume histograms for bone marrow in trabecular bone. Physics Med Biol 2001; 46: 1149–61.
   Google Scholar
• Lothe RA, Smith-Sörensen B, Hektoen M, Stenwig AE, Mandahl N, Smter G, Mertens F. Biallelic inactivation of TP3 rarely contributes to the development of malignant peripheral nerve sheath tumors. Genes Chromosomes Cancer 2001; 30: 202–6.
   PubMedGoogle Scholar
• Menghi-Sartorio S, Mandahl N, Mertens F, Picci P. Knuutila S. DNA copy number amplifications in sarcomas with homoge-neously staining regions and double minutes. Cytometry 2001; 46: 79–84.
   Google Scholar
• Mertens F, Lothe RA. Peripheral nerve sheath tumors. Atlas Genet Cytogenet Oncol Haematol. URL, 2001.
   Google Scholar
• Meza-Zepeda LA, Berner JM, South A, Henriksen J, Dahlberg AB, Godager LH, Pedeutour F, Nizetic D, Forus A, Myklebost 0. Characterisation of ectopic sequences from tumour-associ-ated, truncated HMGIC genes shows recurrent involvement of specific chromosomal regions. Genes Chromosomes Cancer 2001; 31: 264–73.
   Google Scholar
• Onda M, Olafsen T, Tsutsumi Y, Bruland OS, Pastan I. Cyto-toxicity of anti-osteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and truncated Pseudomonas Exotoxin A. J Immunother 2001; 24: 144–50.
   Google Scholar
• Pedeutour F, Bjerkehagen B, Sirvent N, Meza-Zepeda L, Coindre JM, Berner JM, Myklebost 0, Forus A. A new type of chro-mosome 12 derived markers found in a well-differentiated liposarcoma proceedings of the AACR, 2001.
   Google Scholar
• Picci P. Vanel D, Briccoli A, Talle K, Haakenaasen U, Malaguti C, Monti C, Ferrari S, Bacci G, Saeter G, Alvegard TA. Com-puted tomography of pulmonary metastases from osteosar-coma: the less poor technique. Ann Oncol 2001; 12: 1601–4.
   Google Scholar
• Schutte BC, Carpten JD, Forus A, Gregory SG, Horii A, White PS. Report of the sixth international workshop on human chromosome 1 mapping 2000. Cytogenet Cell Genet 2001; 92: 23–41.
   PubMedGoogle Scholar
• Trovik CS, Bauer HCF, Andersson H, Berlin 0, Blomqvist C, Erlanson M, Gustafson P. Klepp R, Smter G, Wahlström 0. Local recurrence of deep-seated, high-grade, soft tissue sar-coma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001; 72: 160–6.
   Google Scholar
• Anderson PM, Wiseman GA, Dispenzeri A, Amdt C, Hartman LC, Smithson WA, Mullan BP, Bruland OS. High dose 153-samarium Ethylene Diamine Tetramethylene Phosphonate: Low toxicity of skeletal irradiation in patients with osteo-sarcoma and bone metastases. J Chin Oncology 2002; 20(1): 189–96.
   PubMed Web of Science ®Google Scholar
• Ayala AG, Czemiak B, Raymond AK, Knuutila S. Periosteal osteosarcoma. In World Health Organization Classification of Tumours. Pathology & Genetics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon 2002: 282–3.
   Google Scholar
• Bacci G, Mercuri M, Ferrari S, Longhi A, Alvegard T, Saeter G, Donati D, Manfrini M, Lan i S, Forth C. High-dose ifosfamide in combination with high-dose methotrexate, doxorubicin and cisplatin in the neoadjuvant treatment of osteosarcoma of the extremities: Preliminary results of a Rizzoli-Scandinavian Sar-coma Group pilot study. J Chemother 2002; 14: 198–206.
   PubMed Web of Science ®Google Scholar
• Brekken C, Veliyulin E, Singstad TE, Frengen J, Eikenes L, Davies CD, Bruland OS, Gribbestad IS. Chemoirradiation of human osteosarcoma in mice: Early response assessment by magnetic reonance imaging. hit J Cancer, 2002; 13: 95.
   Google Scholar
• Chow E, Jackson SY, Hoskin P. Cola LR, Bentzen SM, Blitzer PH (on behalf of the International Bone Metastases Consensus Working Party - Bruland OS, member). International consen-sus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002; 64: 275–80.
   Google Scholar
• Davies CDL, Bruland OS, Tan MR. Hylauronidase improves distribution of liposomal doxorubicin in human osteosarcoma xenografts. hit J Cancer 2002; 13: 425.
   Google Scholar
• Dickens DS, Kozielski R, Khan J, Forus A, Cripe TP. Cyclo-oxygenase-2 Expression in Pediatric Sarcomas. Pediatr Dev Pathol 2002; 5: 356–64.
   PubMed Web of Science ®Google Scholar
• Eikenes L, Bruland OS, Davies CDL. Collagenase increases the transcapillary gradient and the antibody uptake in human osteosarcoma xenografts. hit J Cancer 2002; 13: 151–2.
   Google Scholar
• Forest M, de Pinieux G, Knuutila S. Secondary osteosarcomas. hi World Health Organization Classification of Tumours. Pathol-ogy & Genetics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon 2002: 277–8.
   Google Scholar
• Hall KS, Smeland S, Trovik C, Monge 0, Follerfis G. Sarkomer. In: Cytostatika - medikamentell kreftbehandling (in Norwe-gian). Institutt for farmakoterapi og Den Norske Kreftforen-ing. 7.utg. 2002 (nettutgave)
   Google Scholar
• Hauser M, Lloret I, Skjeldal S. Pelvic compartmental anatomy in the planning of image-guided musculoskeletal biopsies: a pictorial review. Radiology 2002; 225(P): 729–30.
   Google Scholar
• Hauser M, Lloret I, Skjeldal S. Stepwise approach to image-guided biopsy of cystic bone lesions: a pictorial review. Radi-ology 2002; 225(P): 730.
   Google Scholar
• Heim S. Chondro-osseous tumors. In: World Health Organiza-tion Classification of Tumours: Pathology, and genetics of tumours of soft tissue and bone. (Eds: Fletcher CDM, Unni KK, Mertens F. IARC Press, Lyon, 2002.
   Google Scholar
• Henriksen G, Breist81 K, Bruland OS, Fodstad 0, Larsen R. Significant antitumor effect from bone-seeking, alpha particle-emitting radium-223 demonstrated in an experimental skeletal metastases model. Cancer Res 2002; 62: 3120–5.
   Google Scholar
• Inwards CY, Knuutila S. Low grade central osteosarcoma. In World Health Organization Classification of Tumours. Pathol-ogy & Genetics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon, 2002: 275–6.
   Google Scholar
• Kvirmsland Y, Bruland OS, Moe L, Skretting A. A method for measurement of the utake patterns of two beta-emitting radionuclides in the same tissue ection with a digital silicon detector: Application to a study of 89-strontium and 153-samariumEDTMP in a dog with spontaneous osteosarcoma. Eur J Nucl Med 2002; 29: 191–7.
   Google Scholar
• Lamovec J, Knuutila S. Kaposi sarcoma. In World Health Organi-zation Classification of Tumours. Pathology & Genetics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon, 2002; 170–2.
   Google Scholar
• Mandahl N, Gustafson P. Mertens F, Akerman M, Baldetorp B, Gisselsson D, Knuutila S, Bauer HCF, Larsson 0. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer 2002; 33: 188–200.
   PubMedGoogle Scholar
• Matsuno T, Okada K, Knuutila S. Telangiectatic osteosarcoma. In World Health Organization Classification of Tumours. Pathol-ogy & Genetics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon, 2002: 271–2.
   Google Scholar
• Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, God-ager LH, South A, Marenholtz I, Lioimi M, FlOrenes VA, Mmlandsmo GM, Seim M, Mischke D, Nizetic D, Ragoussis I, Tarkkanen M, Nesland J, Knuutila S, Myklebost 0. Posi-tional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 2002; 21: 2261–9.
   Google Scholar
• Micci F, Teixeira MR, Bjerkehagen B, Heim S. Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH. Cytogen Genome Res 2002; 97, 13–9.
   PubMedGoogle Scholar
• Mikkelsen IM, Johnsen iT, Halvorsen H, Bruland OS, Flxgstad T. Human osteosarcoma and neuroblastoma cell lines are sensi-tized to apoptosis by TRAIL and interferon-gamma treatment. Int J Cancer 2002; 13: 166.
   Google Scholar
• Olerud HM, Olberg S, Widmark A, Hauser M. Physician and patient radiation dose in various CT-guided biopsy protocols. Book of Abstracts, 6th European ALARA Network on "Occu-pational Optimisation in the Medical Field and Radiopharma-ceutical Industry". Madrid, 23–25 October 2002.
   Google Scholar
• Panagoupoulos I, Mertens F, Isaksson M, Domanski H.A, Brosjö 0, Heim S, Bjerkehagen B, Sciot R, Dal Cin P. Fletcher J.A, Fletcher CDM, Mandahl N. Molecular genetic charac-terization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes and Cancer 2002; 35: 13–9.
   Google Scholar
• Raymond AK, Ayala AG, Knuutila S. Conventional osteosa-rcoma. In World Health Organization Classification of Tumours. Pathology & Genetics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon, 2002: 264–70.
   Google Scholar
• ScheistrOen M, Nordal R, Onsrud M, Lie K, Hall KS. Uterussar-kom. In: Veileder i gynekologisk onkologi 2002: 117–122.
   Google Scholar
• Smeland S, Bruland OS, Jakobson Aa, Strander H. Is there a role of immunotherapy in the current management of osteosar-coma? Int J Cancer 2002; 13: 37–8.
   Google Scholar
• Smeland S, Muller C, Alvegird TA, Wiklund T, Wiebe T, Bkirk 0, Stenwig AE, Willen H, Holmstibm T, Folleris G, Brosj8 0, Kivioja A, Hasson K, Monge 0, Swter G. Scandinavian Sarcoma Group Osteosarcoma Study SSG Vifi prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2002; 39(4): 488–94.
   Google Scholar
• Swter G, Sundby Hall K, Bruland OS, Solheim 0.P, fløie J, Folleths G, Helgerud P. Stenwig AE, Bjerkehagen B, Talle K, Taksdal I, Winderen M. Bein- og blötvevssarkomer behandlet ved Det Norske Radiumhospital 1980–99. Tidskr Nor Laege-foren 2002; 122: 2089–94.
   Google Scholar
• Unni KK, Knuutila S. Parosteal osteosarcoma. In World Health Organization Classification of Tumours. Pathology & Genet-ics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon, 2002: 279–81.
   Google Scholar
• Wold L, McCarthy E, Knuutila S. High grade surface osteo-sarcoma. In World Health Organization Classification of Tumours. Pathology & Genetics, Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK & Mertens F (eds). IARC Press, Lyon, 2002: 284–5.
   Google Scholar
• Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, Fisher C, Shipley J, Bjerkehagen B, Myklebost 0, Larsson 0. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and Dl. A link between t(X;18) (p11.2; q11.2) and the cell cycle machinery. Oncogene 2002; 21: 5791–6.
   Google Scholar
• Brandal P. Micci F, Bjerkehagen B, Eknoes M, Larramendy M, Lothe RA, Knuutila S, Heim S. Molecular cytogenetic charac-terization of desmoid tumors. Cancer Genet Cytogenet 2003; 146: 1–7.
   PubMedGoogle Scholar
• Henriksen G, Fisher DR, Roeske JC, Bruland OS, Larsen R. Tar-geting of osseous sites with alpha emitting 223Ra: Comparison with beta emitter 895r(Metastron) with particular emphasis on biodistribution and dosimetry. J Nucl Med 2003; 44(2): 252–9.
   Google Scholar
• Asp J, Thornemo M, Inerot S, Lindahl A. The helix-loop-helix transcription factors Id1 and Id3 have a role in control of cell division in human normal and neoplastic chondrocytes. FEBS Letters 1998; 438(1-2): 85–90.
   PubMedGoogle Scholar
• Berlin 6, Trovik CS, Bauer HCF. 63 soft tissue sarcomas with two or more local recurrences in the Scandinavian Sarcoma Group Central Registry - a preliminary report. Acta Orthop Scand 1998; 69: 32.
   Google Scholar
• Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical overview with differential diag-nostic considerations. Seminars in Diagn Pathol 1998; 15: 102–10.
   Google Scholar
• Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell tumor of soft tissue: Diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol, 1998; 22: 779–94.
   PubMed Web of Science ®Google Scholar
• Gisselsson D, Andreasson P. Meis-Kindblom JM, Kindblom LG, Mertens F, Mandahl N. Amplification of 12q13 and 12q15 sequences in a sclerosing epithelioid fibrosarcoma. Cancer Genet Cytogenet 1998; 107: 102–6.
   PubMedGoogle Scholar
• Kindblom LG, Meis-Kindblom JM, Havel G, Busch C. Benign epithelioid schwannoma. Am J Surg Pathol 1998; 22: 762–70.
   PubMed Web of Science ®Google Scholar
• Kindblom LG, Meis-Kindblom JM, Stemnan G, Gunterberg B. Muskuloskeletal tumörforskning pa frammarsch. Corpus Medicum 1998; 1: 2–9.
   Google Scholar
• Kindblom LG, Meis-Kindblom JM, Widéhn S: To the Editor. Reply. "Unique secretion phenomenon in lipogenic tumors". Hum Pathol 1998; 29: 99–100.
   Google Scholar
• Kindblom LG, Remotti H, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT) - Gastroin-testinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Ara J Pathol 1998; 152: 1259–69.
   Google Scholar
• Meis-Kindblom JM, Kindblom LG. Acral myxoinflammatory fibroblastic sarcoma: A low grade tumor of the hands and feet. Am J Surg Pathol 1998; 22: 911–24.
   Google Scholar
• Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue. A study of 80 cases. Am J Surg Pathol 1998; 22: 683–97.
   Google Scholar
• Meis-Kindblom JM, Kjellstrom C, Kindblom LG. Inflammatory fibrosarcoma: Update, reappraisal and perspective on its place in the spectrum of inflammatory myofibroblastic tumors. Seminars in Diagn Pathol 1998; 15: 133–43.
   Google Scholar
• Angervall L, Persson S, Stenman G, Kindblom LG. Large cell, epithelioid, teleangiactic osteoblastoma: a unique pseudo-sarcomatous variant of osteoblastona. Hum Pathol 1999; 30: 1254–9.
   PubMedGoogle Scholar
• Bergh P. Meis-Kindblom JM, Gherlinzoni F, Berlin 6, Bacchini P. Bertoni F, Gunterberg B, Kindblom LG. Synovial sarcoma: Identification of high and low risk groups. Cancer 1999; 85: 2596–607.
   Google Scholar
• Helou K, Wallenius V. Qiu Y, öhman F, Sthhl F, Klinga-Levan K, Kindblom LG, Mandahl N, Jansson JO, Levan G. Ampli-fication and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas. 1999; 18(21): 3226–34.
   Google Scholar
• Meis-Kindblom JM, Bergh P. Gunterberg B, Kindblom LG. Extraskeletal myxoid chondrosarcoma A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol 1999; 23(6): 636–50.
   Google Scholar
• Meis-Kindblom JM, Bjerkehagen B, Bolling T, Domanski H, Halvorsen TB, Larsson 0, Linens P. Myhre-Jensen 0, Stenwig E, Virolainen M, Willén H, Akerman M, Kindblom LG. Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register: The peer review committee experience. Acta Orthop Scand Suppl 285 1999; 70: 18–26.
   Google Scholar
• Sjogren H, Meis-Kindblom J, Kindblom L-G, Armin P. Sten-man G. Fusion of the EWS related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma. Cancer Res1999; 59: 5064–7.
   PubMedGoogle Scholar
• Skytting B, Meis-Kindblom J, Larsson 0, Virolainen, Perfekt R, Akerman M, Kindblom L-G. Synovial sarcoma - identification of favorable and unfavorable histologic types: A Scandinavian sarcoma group study of 104 cases. Acta Orthop Scand 1999; 70: 543–54.
   Google Scholar
• Asp J, Sangiorgi L, Inerot SE, Lindahl A, Molendini L, Benassi MS, Picci P. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. Int J Cancer 2000; 85(6): 782–6.
   Google Scholar
• Bergh P. Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordomas of the sacrum and mobile spine: a study of 39 patients. Cancer 2000; 88: 2122–34.
   Google Scholar
• Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M, Bridge JA. Loss of 14q and 22q in gastrointes-tinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet 2000; 120: 111–6.
   PubMed Web of Science ®Google Scholar
• Gimita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson 0. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells. Oncogene 2000; 19: 4298–301.
   Google Scholar
• Sjogren H, Wedell B, Meis-Kindblom JM, Kindlom LG, Sten-man G. Fusion of the NT-12-terminal domain of the basic HLH protein TCF12 to TEC in an extraskeletal myxoid chondro-sarcoma with translocation of t(9;15)(q22;q21)1. Cancer Res 2000; 60: 6832–5.
   Google Scholar
• Trovik CS, Bauer HCF, Alvegird TA, Anderson H, Blomquist C, Berlin 6, Gustafson P. Saeter G, Walloe A. Surgical margin, local recurrence and metastasis in soft tissue sarcoma; 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000; 36(6): 710–6.
   Google Scholar
• Trovik CS, Gustafson P. Bauer HCF, Saeter G, Klepp R, Berlin 6, Erlanson M, Wahlström 0, Raabe N. Consequences of local recurrence of soft tissue sarcoma. 205 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2000; 71: 488–95.
   Google Scholar
• Wallenius VR, Hisaoka M, Helou K, Levan G, Mandahl N, Meis-Kindblom JM, Kindblom LG, Jansson JO. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and pres-ence of truncated activated intracellular HGF receptor frag-ment in locally aggressive/malignant human musculoskeletal tumors. Am J Pathol 2000; 156: 821–9.
   Google Scholar
• Asp J, Brantsing C, Benassi MS, Inerot S, Sangiorgi L, Picci P. Lindahl A. Changes in p14(ARF) do not play a primary role in human chondrosarcoma tissues. Int J Cancer 2001; 93(5): 703–5.
   Google Scholar
• Asp J, Inerot S, Block JA, Lindahl A. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosar-coma. J Orthop Res 2001; 19(1): 149–54.
   PubMedGoogle Scholar
• Bauer HCF, Trovik CS, Alvegard TA, Berlin 6, Erlanson M, Gustafson P. Klepp R, Moller TR, Rydholm A, Saeter G, Wahlstrom 0, Wiklund T. Monitoring referral and treatment in soft tissue sarcoma: Study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001: 72; 150–9.
   Google Scholar
• Bergh P. Gunterberg B, Meis-Kindblom JM, Kindblom LG. Prognostic factors and outcome of pelvic, sacral and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 2001; 91: 1201–12.
   Google Scholar
• Einbeigi Z, Bergman A, Kindblom LG, Martinsson T, Meis-Kind-blom JM, Nordling M, SuurkOla M, Wahlström J, Wallgren A, Karlsson P. A founder mutation of the BRCA1 gene in western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 2001; 37: 1904–9.
   Google Scholar
• Gebre-Medhin M, Kindblom LG, Wennbo H, Törnell J, Meis-Kindblom JM. Growth hormone receptor is expressed in human breast cancer. Am J Pathol 2001; 158: 1217–22.
   Google Scholar
• Lemos M, Kindblom LG, Meis-Kindblom JM, Ryd W, Willén H. Fine needle aspiration characteristics of hibemoma. Cancer Cytololgy 2001; 93: 206–10.
   Google Scholar
• Lemos M, Kindblom LG, Meis-Kindblom JM, Ryd W, Willén H. Fine needle aspiration features of pilomatrixoma. Cancer Cytology 2001: 93: 252–6.
   Google Scholar
• Meis-Kindblom JM, Sjogren H, LG Kindblom, Peydró-Mellquist A, Roijer E, Aman P. Stenman G. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Vir-chows Arch 2001; 439: 141–51.
   Google Scholar
• Sheng WQ, Hashimoto H, Okamoto S, Ishida T, Meis-Kindblom JM, KindblomLG, Hisaoka M. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protu-berans. J Pathol 2001; 194: 88–94.
   Google Scholar
• Sheng WQ, Hisaoka M, Okamoto S, Tanaka A, Meis-Kindblom JM, Kindblom LG, Ishida T, Nojina T, Hashimoto H. Con-gental-infantile fibrosarcoma: A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcript using paraffin-embedded tissues. Am J Clin Pathol 2001: 115: 348–55.
   Google Scholar
• Trovik CS, Bauer HCF, Berlin 0, Tukiainen E, Erlanson M, Gus-tafson P. Klepp R, Saeter G, Wahlstrom 0. Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001: 72; 160–6.
   Google Scholar
• Abramsson A, Berlin 0, Papayan H, Paulin D, Shani M, Bet-sholtz C. Analysis of mural cell recruitment to tumor vessels. Circulation 2002; 105: 112–7.
   Google Scholar
• Andersson J, Sjogren H, Meis-Kindblom JM, Stenman G, Armin P. Kindblom LG. The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors. Am J Pathol 2002; 160: 15–22.
   Google Scholar
• Einbeigi Z, Meis-Kindblom JM, Kindblom LG, Wallgren A, Karlsson P. Clustering of individuals with both breast and ovarian cancer - a possible indicator of BRCA founder muta-tions. Acta Oncol 2002; 41: 153–7.
   PubMed Web of Science ®Google Scholar
• Kindblom L-G, Meis-Kindblom JM, in WHO Classification of Tumors. Volume 4. Pathology and Genetics of Soft Tissue Tumors. 2002. Eds Kleihues P. Unni KK, Mertens F, Fletcher CD, Sobin L. IARC. "Chondroid Lipoma".
   Google Scholar
• Kindblom L-G, Meis-Kindblom JM, in WHO Classification of Tumors. Volume 4. Pathology and Genetics of Soft Tissue Tumors. 2002. Eds Kleihues P. Unni KK, Mertens F, Fletcher CD, Sobin L. IARC. "Myxoinflammatory Fibroblastic Sar-coma".
   Google Scholar
• Meis-Kindblom JM, Kindblom LG, in WHO Classification of Tumors. Volume 4. Pathology and Genetics of Soft Tissue Tumors. 2002. Eds Kleihues P. Unni KK, Mertens F, Fletcher CD, Sobin L. IARC. "Myolipoma of Soft Tissue".
   Google Scholar
• Meis-Kindblom JM, Kindblom LG, in WHO Classification of Tumors. Volume 4. Pathology and Genetics of Soft Tissue Tumors. 2002. Eds Kleihues P. Unni KK, Mertens F, Fletcher CD, Sobin L. IARC. "Sclerosing Epithelioid Fibrosarcoma".
   Google Scholar
• Okamoto S, Hisaoka M, Meis-Kindblom JM, Kindblom L-G, Hashimoto H. Juxt-articular myxoma and intramuscular myxoma are two distinct entities. Activating Gsa mutation at Arg 201 codon does not occur in juxta-articular myxoma. Virchows Arch 2002; 440: 12–15.
   Google Scholar
• Bumming P. Andersson J, Meis-Kindblom JM, Klingenstiema H, Engstrom K, Stiemer U, Wängberg B, Jansson S, Ahlman H, Kindblom LG, Nilsson B. Neoadjuvant, adjuvant and pallia-tive treatment of gastrointestinal stromal tumours (GIST) with imatinib - a centre-based study of 17 patients. Br J Cancer 2003; 89: 460–4.
   Google Scholar
• Dalén M, Bergh P. Gunterberg B. Desmoid tumors. A clinical review of 30 patients with more than 20 years' follow-up. Acta Orthop Scand 2003; 74 (4): 455–9.
   Google Scholar
• Einbeigi Z, Bergman A, Karlsson P. Kindblom LG, Martinsson T, Meis-Kindblom J, Nordling M, Wahlstrom J, Wallgren A. Population study on brca mutations in women with breast and ovarian cancers in western Sweden. Breast 2003, 12 Suppl 1: S17.
   Google Scholar
• Hisaoka M, Okamoto S, Koyama S, Ishida T, Imamura T, Kanda H, Kameya T, Meis-Kindblom JM, Kindblom L-G,Hashimoto H. Microtubule-associated protein-2 and class III B-tubulin in extraskeletal myxoid chondrosarcoma. Mod Pathol 2003; 16: 453–9.
   Google Scholar
• Hisaoka M, Shimajiri S, Matsuki Y, Meis-Kindblom JM, Kind-blom LG, Li XQ, Wang J, Hashimoto H. Inflammatory myo-fibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype. Pathol International 2003; 53: 376–81.
   Google Scholar
• Kindblom LG, Widéhn S, Meis-KindblomJM. The role of elec-tron microscopy in the diagnosis of pleomorphic sarcomas of soft tissue. Seminars in Diagn Pathol 2003; 20: 72–81.
   PubMed Web of Science ®Google Scholar
• Nilsson B, Andersson J, Meis-Kindblom J, Kindblom LG, Eng-strom K, Stiemer U, Bumming P. Ahlman H. Nya ron om uppkomsten av GIST har lett till ny medicinsk behandling. Läkartidning 2003; 100: 930–8.
   Google Scholar
• Sjogren FT. Meis-Kindblom JM, örndal C, Bergh P. Ptaszynski K, Aman P. Kindblom LG, Stenman G. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma - phenotypic, cytogenetic, molecular genetic and gene expression profiles. Am J Pathol 2003; 162: 781–92.
   Google Scholar
• Unni KK, Kindblom LG, Bridge J. Atlas of Tumor Pathology. Tumors of the Skeleton (in press).
   Google Scholar
• Dal Cin P. Sciot R, Fletcher CDM, Samson I, De Vos R, Mandahl N, Willén H, Larsson 0, Van Den Berghe H. Inflammatory leiomyosarcoma may be characterized by specific near-hap-loid chromosome changes. J Pathol 1998; 185: 112–5.
   Google Scholar
• Gisselsson D, Andreasson P. Meis-Kindblom JM, Kindblom LG, Mertens F, Mandahl N. Amplification of 12q13 and 12q15 sequences in a sclerosing epithelioid fibrosarcoma. Cancer Genet Cytogenet 1998; 107: 102–6.
   PubMedGoogle Scholar
• Gisselsson D, Hoglund M, Mertens F, Mitebnan F, Mandahl N. Chro-mosomal organization of amplified chromosome 12 sequences in rnesenchyrnal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer 1998; 23: 203–12.
   Google Scholar
• Gisselsson D, Hoglund M, O'Brien KP, Dumanski JP, Mertens F, Mandahl N. A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL 1A1 and PDGFB sequences. Cancer Lett 1998; 133: 129–34.
   Google Scholar
• Iliszko M, Mandahl N, Mrozek K, Denis A, Pandis N, Pejovic T, Babinska M, Nedoszytko B, Debniak J, Emerich J, Hrabowska M, Bloomfield CD, Limon J. Cytogenetics of uterine sarco-mas: Presentation of eight new cases and review of the litera-ture. Gynecol Oncol 1998; 71: 172–6.
   Google Scholar
• Kullendorf CM, Donnér M, Mertens F, Mandahl N. Chromo-somal aberrations in a consequtive series of childhood rhab-domyosarcoma. Med Pediatr Oncol 1998; 30: 156–9.
   PubMedGoogle Scholar
• Mandahl N, Mertens F, Willén H, Rydholm A, Kreicbergs A, Mitelman E Nonrandom pattern of telomeric associations in atypical lipomatous tumors with ring and giant marker chro-mosomes. Cancer Genet Cytogenet 1998; 103: 25–8.
   PubMedGoogle Scholar
• Mertens F, Fletcher CDM, Dal Cin P. De Weyer I, Mandahl N, Mitehnan F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Varmi R, Willén H. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with mor-phologic and clinical features: a report of the CHAMP study group. Genes Chromosomes Cancer 1998; 22: 16–25.
   Google Scholar
• Nilbert M, Saeter G, Elomaa I, Monge 0, Wiebe T, Alvegärd TA. Ewing's sarcoma treatment in Scandinavia 1984–1990. 10-year result of the Scandinavian Sarcoma Group Protocol SSG IV. Acta Oncol, 1998; 37(4): 375–8.
   Google Scholar
• O'Brien KP, Seroussi E, Dal Cin P. Sciot R, Mandahl N, Fletcher JA, Turc-Carel C, Dumanski JP. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 1998; 23: 187–93.
   PubMed Web of Science ®Google Scholar
• Rydholm A. Improving the management of soft tissue sarcoma. Diagnosis and treatment should be given in specialist centres. BMJ. 1998 Jul 11; 317(7151): 93–4. No abstract available.
   Google Scholar
• Schuborg C, Mertens F, Rydholm A, Brosj8 0, Dictor M, Mitel-man F, Mandahl N. Cytogenetic analysis of four angiosar-comas from deep and superficial soft tissue. Cancer Genet Cytogenet 1998; 100: 52–6.
   PubMedGoogle Scholar
• Willén H, Akerman M, Dal Cin P. De Weyer I, Fletcher CDM, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Varmi R. Comparison of chromosomal patterns with clinical features in 165 lipomas. A report of the CHAMP study group. Cancer Genet Cytogenet 1998; 102: 46–9.
   Google Scholar
• Akerman M, Domanski H. Fine needle aspiration (FNA) of bone tumors: with special emphasis on definitive treatment of primary malignant bone tumors based on FNA. Current Diagnostic Pathology, 1998; 5: 82–92.
   Google Scholar
• Akerman M, Willén H. Critical review on the role of fine needle aspiration in soft tissue tumors. Pathology Case Reviews 1998; 3: 111–7.
   Google Scholar
• Alvegard TA, Bauer HCF, Blomqvist C, Moller T, Rydholm A, Saeter G. The Scandinavian Sarcoma Group. Background, organization and the Central Register - the first 20 years. Acta Orthop Scand Suppl 285 1999; 70: 3–7.
   Web of Science ®Google Scholar
• Bauer HCF, Alvegard TA, Berlin 0, Erlanson M, Gustafson P. Kivioja A, Klepp R, Lehtinen T, Lindholm P. Moller TR, Ryd-holm A, Saeter G, Trovik CS, Wahlström 0, Wiklund T. The Scandinavian Sarcoma Group Register. Acta Orthop Scand Suppl 285 1999; 70: 41–4.
   Google Scholar
• Berner JM, Sorlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, Brogger A, Myklebost 0, Lothe RA. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumours: Studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer 1999; 26: 151–60.
   Google Scholar
• Einarsdottir H, Söderlund V, Larsson 0, Mandahl N, Bauer HCF. 110 subfascial lipomatous tumors. MR and CT findings versus histopathological diagnosis and cytogenetic analysis. Acta Radiol 1999; 40: 603–9.
   Google Scholar
• Elomaa I, Blomqvist C, Saeter G, Nilbert M, Monge OR, Wiebe T, Alvegard TA. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 69–73.
   Google Scholar
• Femberg JO, Wiklund T, Monge OR, Sundby Hall K, Sater G, Alvegad TA, Strander H. Chemotherapy in soft tissue sar-coma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 62–8.
   Google Scholar
• Fletcher CD, Dal Cin P. de Weyer I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van den Berghe H, Vanni R, Willen H. Correlation between clinico-pathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. Am J Pathol 1999 Jun; 154(6): 1841–7.
   Google Scholar
• Gisselsson D, Domanski HA, Hoglund M, Carlén B, Mertens F, Willén H, Mandahl N. Unique cytological features and chro-mosome aberrations in chondroid lipoma. A case report based on fine needle aspiration cytology, histopathology, electron microscopy, chromosome banding, and molecular cytogenet-ics. Am J Surg Pathol 1999; 23: 1300–4.
   Google Scholar
• Gisselsson D, Hoglund M, Mertens F, Dal CM P. Mandahl N. Hibemomas are characterised by homozygous deletions in the multiple endocrine neoplasia type I region. Am J Pathol 1999; 155: 61–6.
   Google Scholar
• Gisselsson D, Hoglund M, Mertens F, Johansson B, Dal Cin P. Van den Berghe H, Eamshaw WC, Mitelman F, Mandahl N. The stucture and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum Genet 1999; 104: 315–25.
   Google Scholar
• Gisselsson D, Hoglund M, Mertens F, Mandahl N. Variable stability of chromosomes containing amplified alpha satellite sequences in human mesenchymal tumours. Chromosoma 1999; 108: 271–7.
   PubMedGoogle Scholar
• Gustafson P. Amer M. Soft tissue sarcoma of the upper extremity. Descriptive data and outcome in a population-based series of 108 patients. J Hand Surg (Am), 1999; 24A(4): 668–74.
   Google Scholar
• Gustafson P. Baldetorp B, Ferno M, Akerman M. Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma. Br J Cancer 1999; 79(7/8): 1205–9.
   Google Scholar
• Helou K, Wallenius V, Qiu Y, Oilman F, Stahl F, Klinga-Levan K, Kindblom LG, Mandahl N, Jansson J-0, Levan G. Ampli-fication and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas. Oncogene 1999: 18: 3226–34.
   Google Scholar
• Kullendorf CM, Mertens F, Donnér M, Wiebe T, Akerman M, Mandahl N. Cytogenetic aberrations in Ewing's sarcoma. Are secondary changes associated with clinical outcome? Med Pediatr Oncol 1999; 32: 79–83.
   Google Scholar
• Larramendy ML, Mandahl N, Mertens F, Blomqvist C, Kivioja AH, Karaharju E, Valle J, Bohling T, Tarkkanen M, Rydholm A, Akerman M, Bauer HCF, Anttila JP, Elomaa I, Knuutila S. Clinical significance of genetic imbalances revealed by com-parative genomic hybridization in chondrosarcomas. Hum Pathol 1999 Oct; 30(10): 1247–53.
   Google Scholar
• Mandahl N, Mertens F, Mitelman E Genetic changes in bone and soft tissue tumors. Acta Orthop Scand Suppl 285 1999; 70: 30–40.
   Web of Science ®Google Scholar
• Meis-Kindblom JM, Bjerkehagen B, Bohling T, Domanski H, Halvorsen TB, Larsson 0, Lilleng P. Myhre-Jensen 0, Stenwig E, Virolainen M, willen H, Akerman M, Kindblom LG. Morphologic reviev of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SGG) register. The peer-review committee experience. Acta Ortop Scand Suppl 285 1999; 70: 18–26.
   Google Scholar
• Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhl& M, Larsson 0. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 1999; 59: 3180–4.
   Google Scholar
• Nilsson J, Gustafson P. Ortopedisk behandling av skelettmetas-taser i backen och extremiteter. Läkartidningen 1999; 96(9): 1000–5.
   PubMedGoogle Scholar
• Pandis N, Bardi G, Petersson C, Apostolikas N, Mandahl N. Cytogenetic findings in a malignant fibrous histiocytoma of the breast. Cancer Genet Cytogenet 1999: 108: 87–9.
   PubMedGoogle Scholar
• Panoutsakopoulos G, Pandis N, Kyriazoglou I, Gustafson P. Mertens F, Mandahl N. Recurrent t (16;17)(q22;p13) in aneurysmal bone cysts. Genes Chromosomes Cancer 1999; 26(3): 256–66.
   Google Scholar
• Petit MMR, Schoenmakers EFPM, Huysmans C, Geurts JMW, Mandahl N, Van De Ven WJM. LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 1999; 57: 438–41.
   Google Scholar
• Rydholm A, Gustafson P. Alvegard TA, Blomqvist C, Saeter G. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 50–7.
   Google Scholar
• Saeter G, Wiebe T, Wiklund T, Monge 0, Wahlqvist Y, Engstrom K, Forestier E, Holmstrom T, Stenwig AE, Willén H, Brosj8 0, Folleras G, Alvegard TA, Strander H. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 1999; 70: 74–82.
   Google Scholar
• Sciot R, Rosai J, Dal Cin P. de Weyer I, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rydholm A, Tallini G, van den Berghe H, Vanni R, Willen H. Analysis of 35 cases of local-ized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group. Mod Pathol 1999; 12: 576–9.
   Google Scholar
• Skytting BT, Bauer HCF, Perfekt R, Huuhtanen T, Alvegard TA, Berlin 6, Gustafson P. Klepp R, Löfvenberg R, Saeter G, Trovik CS, Wahlström 0. Clinical course in synovial sarcoma: A Scandinavian Sarcoma Group study of 104 patients. Acta Orthop Scand 1999; 70(6): 536–42.
   Google Scholar
• Thelin-Järnum S, Lassen C, Panagopoulos I, Mandahl N, Aman P. Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. Int J Cancer 1999; 83: 30–3.
   Google Scholar
• Dal CM P. Sciot R, Brys P. De Weyer I, Doilman H, Fletcher CD, Jonsson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Tallini G, Van den Berghe H, Varmi R, Willen H. Recurrent chromosome aberrations in fibrous dysplasia of the bone: a report of the CHAMP study group. CHromosomes And MorPhology. Cancer Genet Cytogenet 2000; 122: 30–2.
   Google Scholar
• De Weyer I, Dal CM P. Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Vanni R, Willen H. Cytogenetic, clinical, and mor-phologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. Chromosomes And Morphology. Mod Pathol 2000; 13: 1080–5.
   Google Scholar
• Elomaa I, Blomqvist PI, Saeter G, Akerman M, Stenwig E, Wiebe T, Björk 0, Alvegärd TA. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Grop experience with the SSG IX protocol. Eur J Cancer 2000; 36: 875–80.
   Google Scholar
• Gisselsson D, Mandahl N, Pälsson E, Gorunova L, Hoglund M. Locus-specific multifluor FISH analysis allows physical char-acterization of complex chromosome abnormalities in neopla-sia. Genes Chromosomes Cancer 2000; 28: 347–52.
   Google Scholar
• Gisselsson D, Pettersson L, Hoglund M, Heidenblad M, Gorun-ova L, Wiegant J, Mertens F, Dal CM P. Mitelman F, Mandahl N. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Nail Acad Sci USA 2000; 97: 5357–62.
   Google Scholar
• Mandahl N. Lipoma / benign lipomatous tumors. Liposarcoma / malignant lipomatous tumors. In: Atlas of Genetics, and Cytogenetics on Oncology and Haematology, J-L Huret (Ed.), 2000 http://www.infobiogen.fr/services/chromcancer
   Google Scholar
• Mandahl N, Fletcher CD, Dal CM P. De Weyer I, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Varmi R, Willen H. Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tis-sues: a report from the CHAMP Study Group. Cancer Genet Cytogenet 2000; 116: 66–73.
   Google Scholar
• Mertens F, Dal Cin P. De Weyer I, Fletcher CD, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van Den Berghe H, Vanni R, Willen H. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol. 2000; 190: 31–8.
   Google Scholar
• Mertens F, Larramendy M, Gustavsson A, Gisselsson D, Ryd-holm A, Brosjo 0, Mitelman F, Knuutila S, Mandahl N. Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p. Cancer Genet Cytogenet. 2000; 116: 89–96.
   Google Scholar
• Nilsson J, Gustafson P. Fomander P. Ornstein E. The Harrington reconstruction for advanced periacetabular metastatic destruc-tions - good outcome in 32 patients. Acta Orthop Scand 2000; 71(6): 591–6.
   Google Scholar
• Panagopoulos I, Mencinger M, Dietrich CU, Bjerkehagen B, Saeter G, Mertens F, Mandahl N, Heim S. Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondro-sarcomas with the translocation t(9;17)(q22;q11). Oncogene 2000; 18: 7594–8.
   Google Scholar
• Panagopoulos I, Mertens F, Isaksson M, Mandahl N. A novel FUS/CHOP chimera in myxoid liposarcoma. Biochem Bio-phys Res Cormnun 2000; 279: 838–45.
   PubMedGoogle Scholar
• Sciot R, Dorfman H, Brys P. Dal Cin P. De Weyer I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Tallini G, Van den Berghe H, Varmi R, Willen H. Cytogenetic-morphologic correlations in aneurys-mal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group. Mod Pathol 2000; 13: 1206–10.
   Google Scholar
• Trovik CS, Bauer HCF, Alvegird TA, Anderson H, Blomqvist C, Berlin 6, Gustafson P. Saeter G, Walloe A. Surgical margin, local recurrence and metastatis in soft tissue saroma. Study based on 559 patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000; 36(6): 710–6.
   Google Scholar
• Trovik CS, Gustafson P. Bauer HCF, Saeter G, Klepp R, Berlin 6, Erlanson M, Wahlström 0, Raabe N. Consequences of local recurrence after surgery for soft tissue sarcoma. The Scandi-navian Sarcoma Group experience. Acta Orthop Scand 2000; 71(5): 488–95.
   Google Scholar
• Vanni R, Fletcher CD, Sciot R, Dal Cin P. De Weyer I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Tallini G, Van Den Berghe H, Willen H. Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group. Histopathology 2000; 37: 212–7.
   Google Scholar
• Wallenius V. Hisaoka M, Helou K, Levan G, Mandahl N, Meis-Kindblom JM, Kindblom L-G, Jansson J-0. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF recep-tor fragment in locally aggressive/malignant human musculo-skeletal tumors. Am J Pathol 2000; 156: 821–9.
   Google Scholar
• Waters BL, Panagopoulos I, Allen EF. Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11. Cancer Genet Cytogenet 2000; 121:109–16.
   Google Scholar
• Bauer HCF, Trovik CS, Alvegärd TA, Berlin 6, Erlanson M, Gustafson P. Klepp R, Moller TR, Rydholm A, Saeter G, Wahlstrom 0, Wiklund T. Monitoring referral and treatment in soft tissue sarcoma: study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001; 72(2): 150–9.
   Google Scholar
• Dahl& A, Broberg K, Domanski HA, Toksvig-Larsen S, Lind-strand A, Mandahl N, Mertens E Analysis of the distribution and frequency of trisomy 7 in vivo in synovia from patients with osteoarthritis and pigmented villonodular synovitis. Cancer Genet Cytogenet 2001; 131(1): 19–24.
   Google Scholar
• Domanski HA, Carl& B, Jonsson K, Mertens F, Akerman M. Distinct cytologic features of spindle cell lipoma. A cytologic-histologic study with clinical, radiologic, electron microscopic and cytogenetic correlations. Cancer 2001; 93(6): 381–9. Engellau J, Akerman M, Anderson H, Domanski H A, Rambech E, Alvegird T A, Nilbert M. Tissue-array technique in soft tissue sarcoma: Immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Appl Immunohistochem Mol Morphol 2001; 9(4): 358–63.
   Google Scholar
• Fletcher CDM, Gustafson P. Rydholm A, Willén H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytoma; the prognostic relevance of subclassification. J Clin Oncol 2001; 19(12): 3045–50. (Reprinted in JCO Classic Papers and Current Comments; Sarcoma 2002)
   Google Scholar
• Gisselsson D, Björk J, Hoglund M, Mertens F, Dal CM P. Aker-man M, Mandahl N. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 2001; 158: 199-206. Gisselsson D, Jonson T, Petersen A, Stromback B, Dal Cin P. Hoglund M, Mitelman F, Mertens F, Mandahl N. Telomere dysfunction triggers extensive DNA fragmentation and evolu-tion of complex chromosome abnormalities in human malig-nant tumors. Proc Nail Acad Sci USA 2001; 98: 12683-8. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P. Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PHB, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal CM P. Bridge J. The der(17)ftX;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001; 20: 48–57.
   Google Scholar
• Lothe RA, Smith-Sorensen B, Hektoen M, Stenwig AE, Mandahl N, Saeter G, Mertens E Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors. Genes Chromosomes Cancer 2001; 30: 202–6.
   PubMedGoogle Scholar
• Menghi-Sartorio S, Mandahl N, Mertens F, Picci P. Knuutila S. DNA copy number amplifications in sarcomas with homoge-neously staining regions and double minutes. Cytometry 2001; 46: 79–84.
   Google Scholar
• Mertens F, Lothe RA. Peripheral nerve sheath tumors. In: Atlas of Genetics, and Cytogenetics in Oncology and Haematology. J-L Huret (Ed.), 2001 http://www.infobiogen.fr/services/ chromcancer
   Google Scholar
• Panagopoulos I, Mertens F, Domanski HA, Isaksson M, Brosjo 0, Gustafson P. Mandahl N. No EWS/FLI1 fusion transcripts in giant-cell tumors of bone. Int J Cancer 2001; 93(6): 769–72.
   Google Scholar
• Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Akerman M, Sciot R, Dal CM P. Samsom I, fliszko M, Ryoe J, Debied-Rychter M, Szadowska A, Brosjo 0, Larson 0, Rydholm A, Mandahl N. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 2001; 31(4): 362–72.
   Google Scholar
• Picci P. Vanel D, Briccoli A, Talle K, Haakenaasen U, Malaguti C, Monti C, Ferrari C, Bacci G, Saeter G, Alvegärd TA. Computed tompgraphy of pulmonary metastases from oste-°sarcoma: the less poor technique. A study of 51 patients with histological correlation. Aim Oncol 2001; 12(11): 1601–4.
   Google Scholar
• Tarkkanen M, Wiklund TA, Virolainen MJ, Laffamendy ML, Mandahl N, Mertens F, Blomqvist CP, Tukiainen EJ, Miet-tinen MMA, Elomaa AT, Knuutila S. Comparative genomic hybridization of postirradiation sarcomas. Cancer 2001; 92: 1992–8.
   Google Scholar
• Trovik CS, Bauer HCF, Berlin 0, Tukiainen E, Erlanson M, Gus-tafson P. Klepp R, Saeter G, Wahlström 0. Local recurrence in deep-seated, high-grade soft tissue sarcoma. 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001; 72(2): 160–6.
   Google Scholar
• Wieczorek TJ, Krane J F, Domanski IIA, Akerman M, Carlén B, Misdraji J, Granter SR. Cytologic findings in granular cell tumors, with emphasis on the diagnosis of malignant granular cell tumor by FNA. Cancer 2001; 93(6): 398–408.
   Google Scholar
• Bacci G, Ferrari S, Longhi A, Picci P. Mercuri M, Alvegard TA, Saeter G, Conati D, Manfrini M, Lan i S, Briccoli A, Forth C. High dose Ifosfamide in combination with high dose Methotrexate, Adriamycin and Cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma pilot study. J Chemoth 2002; 14(2): 198–206.
   Google Scholar
• Broberg K, Zhang M, Stromback B, Isaksson M, Nilsson M, Mertens F, Mandahl N, Panagopoulos I. Fusion of RDC1 and HMGIC in lipomas as the result of chromosome aber-rations involving 2q35-37 and 12q13-15. Int J Oncol 2002; 21: 321–6.
   PubMedGoogle Scholar
• Cmalic S, Panagopoulos I, Boquist L, Mandahl N, Stenling R, Löfvenberg R. Establishment and characterization of a human clear cell sarcoma model in nude mice. Int J Cancer 2002; 101:505–11.
   Google Scholar
• Domanski HA. Cytologic features of angioleiomyoma: Cyto-logic-histologic study of 10 cases. Diagn Cytopathol 2002; 27: 161–6
   PubMedGoogle Scholar
• Domanski HA, Carlén B, Jonsson K, Mertens F, Akerman M. Distinct cytologic features of spinclle cell lipoma. A cytologic-histologic study with clinical, electronraicroscopic and cyto-genetic correlations. Cancer Cytopathol 2002; 93: 381–9.
   Google Scholar
• Domanski HA, Gustafson P. Cytological features of primary, recurrent and metastatic dermatofibrosarcoma protuberans. Cancer 2002; 96(6): 351–61.
   PubMedGoogle Scholar
• Dreinhofer KE, Baldetorp B, Akerman M, Ferno M, Rydholm A, Gustafson P. DNA ploidy in soft tissue sarcoma. Comparison of flow and image cytometry with clinical follow-up in 93 patients. Cytometry (Clinical Cytometry) 2002; 50: 19–24. Fletcher CDM, Unni KK, Mertens F (Eds.) World Health Orga-nization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone Lyon: IARC 2002; Press. Gisselsson D, Pälsson E, Hoglund M, Domanski HA, Mertens F, Pandis N, Sciot R, Dal CM P. Bridge JA, Mandahl N. Dif-ferentially amplified chromosome 12 sequences in low- and high-grade osteosarcomas. Genes Chromosomes Cancer 2002; 33(2): 133-140.
   Google Scholar
• Guillou L, Fletcher JA, Fletcher CDM, Mandahl N. Extrapleu-ral solitary fibrous tumour and haemangiopericytoma. In: Fletcher CDM, Unni KK, Mertens F (Eds.): World Health Organization Classification of Tumours. Pathology and Genet-ics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002; pp 86–90.
   Google Scholar
• Gustafson P. Rydholm A. Muskuloskeletala tumörer. Incitament 2002; 6: 547–52.
   Google Scholar
• Kindblom LG, Meis-Kindblom JM, Mandahl N. Chondroid lipoma. In: Fletcher CDM, Unni KK, Mertens F (Eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002, p 30.
   Google Scholar
• Mandahl N, Gustafson P. Mertens F, Akerman M, Baldetorp B, Gisselsson D, Knuutila S, Bauer HCF, Larsson 0. Cytogenic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes and Cancer 2002; 33: 188–200.
   Google Scholar
• Mertens F, Stromberg U, Mandahl N, Cin PD, De Weyer I, Fletcher CD, Mitelman F, Rosai J, Rydholm A, Sciot R, Tal-lini G, Van Den Berghe H, Vanni R, Willen H. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. Cancer Res 2002; 62(14): 3980–4.
   Google Scholar
• Nilsson M, Hoglund M, Panagopoulos I, Sciot R, Dal CM P. Debiec-Rychter M, Mertens F, Mandahl N. Molecular cytoge-netic mapping of recurrent chromosomal breakpoints in teno-synovial giant cell tumors. Virchows Arch 2002; 441: 475-80. Panagopoulos I, Mertens F, Debiec-Rychter M, Isaksson M, Limon J, Kardas I, Domanski HA, Sciot R, Szadowska A, Perek D, Crnalic S, Larsson 0, Mandahl N. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer 2002; 99: 560–7.
   Google Scholar
• Panagopoulos I, Mertens F, Isaksson M, Domanski HA, Brosjo 0, Heim S, Bjerkehagen B, Sciot R, Dal CM P. Fletcher JA, Fletcher CDM, Mandahl N. Molecular genetic characteriza-tion of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 2002; 35: 340–52.
   Google Scholar
• Raddaoui E, Donner LR, Panagopoulos I (2002) Fusion of the FUS and ATF1 genes in a large, deep-seated angiomatoid fibrous histiocytoma. Diagn Mol Pathol 2002; 11: 157-162. Rapp TB, Yang L, Conrad EU 3rd, Mandahl N, Chansky HA (2002) RNA splicing mediated by YB-1 is inhibited by TIS/ CHOP in human myxoid liposarcoma cells. J Orthop Res 2002; 20: 723–9.
   Google Scholar
• Tallini G, Dorfman Fl, Brys P. Dal Cin P. De Weyer I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Sciot R, Van den Berghe H, Varmi R, Willen H. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology(CHAMP) Collaborative Study Group. J Pathol 2002; 196(2): 194-203. Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, Brodin B, Mandahl N, Larsson 0. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: A gain of function of the t(X;18)(p11.2;q11.2) translocation. Cancer Res 2002; 62: 3861–7.
   Google Scholar
• Yang K, Lui W-0, Xie Y, Zhang A, Skytting B, Mandahl N, Lars-son C, Larsson 0. Co-existence of SYT-SSX1 andSYT-SSX2 fusions in synovial sarcomas. Oncogene 2002; 21: 4181–90.
   Google Scholar
• Dahlén A, Debiec-Rychter M, Pedeutour F, Domanski HA, Hoglund M, Bauer HCF, Rydholm A, Sciot R, Mandahl N, Mertens F. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 2003 Feb 20; 103(5): 616–23.
   PubMedGoogle Scholar
• Dahlén A, Panagopoulos I, Rydholm A, Brosjö 0, Wejde J, Mandahl N, Mertens E Fusion, disruption and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 2003; 16(11): 1132–40.
   PubMedGoogle Scholar
• Domanski HA, Carlén B, Mertens F, Akerman M. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation. A case report with fine needle aspiration, histopathology, electron microscopy, and cytogenetics. Ultrastructural Pathol 2003; 27(5): 363–8.
   Google Scholar
• Domanski HA, Rydholm A. The cytology of soft tissue tumours. Monographs in Clinical Cytology, ditor S.R. Orell, vol 16, 2003.
   Google Scholar
• Gustafson P. Akerman M, Alvegird TA., Coindre JM, Fletcher CDM., Rydholm A, Willén H. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion, and microscopic necrosis - the SIN-system. Eur J Cancer 2003; 39: 1568–76.
   Google Scholar
• Rydholm A, Gustafson P. Should tumor depth be included in prognostication of soft tissue sarcoma? BMC Cancer 2003 May 26; 3(1): 17.
   PubMed Web of Science ®Google Scholar
• Storlazzi CT, Mertens F, Domanski H, Fletcher CDM, Wiegant J, Mandahl N. Ring chromosomes and low-grade gene amplifi-cation in an atypical lipomatous tumor with minimal nuclear atypia. Int J Oncol 2003; 23: 67–71.
   PubMedGoogle Scholar
• Storlazzi CT, Mertens F, Mandahl N, Gisselsson D, Isaksson M, Gustafson P. Domanski HA, Panagopoulos I (2003) A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Genes Chro-mosomes Cancer 2003; 37(2): 195–200.
   PubMedGoogle Scholar
• Storlazzi CT, Mertens F, Nascimento A, Isaksson M, Wejde J, Brosj8 0, Mandahl N, Panagopoulos I (2003) Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. Hum Mol Genet 2003; 12(18): 2349–58.
   PubMedGoogle Scholar
• Dal Cin P. Sciot R, Fletcher CDM, Samson I, De Vos R, Mandahl N, Willen H, Larsson 0, Van den Berghe H. Near-haploid may characterize inflammatory leiomyosarcoma as a distinct entity. J Pathol 1998; 185: 112–5.
   Google Scholar
• Jin Y, Jin C, Arheden K, Larsson 0, Bauer HCF, Mandahl N, Mertens E Unbalanced chromosome rearragements in a metastasizing salivary gland tumor with benign histology. Cancer Genet Cytogenet 1998; 102: 59–64.
   PubMedGoogle Scholar
• Mandahl N, Mertens F, Willen H, Rydholm A, Kreicbergs A, Mitelman E Nonrandom pattern of telomeric associations in atypical lipomatous tumors with ring and giant marker chro-mosomes. Cancer Genet Cytogenet 1998; 103: 25–8.
   PubMedGoogle Scholar
• Nilsson G,Wang M, Wejde J, Kanter L, Karl& J, Tani E, Kre-icbergs A, Larsson 0. Reverse transcriptase polymerase chain reaction on fine-needle aspirates for rapid detection of translocations in synovial sarcoma,. Acta Cytologica 1998; 42(6): 1317–24.
   Google Scholar
• Schuborg C, Mertens F, Rydholm A, Brosjö 0, Dictor M, Mitel-man F, Mandahl N. Cytogenetic analysis of four angiosar-comas from deep and superficial soft tissue. Cancer Genet Cytogenet 1998; 100: 52–6.
   PubMedGoogle Scholar
• Szymanska J, Seim M, Skytting B, Larsson 0, Virolainen M, Akerman M, Tarkkanen M, Huuhtanen R, Picci P. Bacchini P. Elomaa I, Knuutila S. Genetic imbalances in 67 synovial sar-coma evaluated by comparative genomic hybridisation. Genes Chromosomes Cancer12998; 23: 213–9.
   Google Scholar
• Trovik CS, Bauer HCF, Brosjö 0, Skoog L, Söderlund V. Fine Needle Aspiration Cytology in the Diagnosis of Recurrent Soft Tissue Sarcoma. Cytopathology 1998; 9: 320–8.
   Google Scholar
• Wang M, Nilsson G, Carlberg M, Dricu A, Wejde J, Kreicbergs A. Specific and sensitive detection of the EWS/FLI-1 fusion protein in Ewing's sarcoma by Western blotting. Virchows Arch 1998; 432: 131–4.
   PubMedGoogle Scholar
• Alvegird TA, Bauer H, Blomqvist C, Möller T, Rydholm A, Saeter G. The Scandinavian Sarcoma Group. Acta Orthop Scand 1999; 70: 3–7.
   Google Scholar
• Bauer H, Alvegird TA, Berlin 6, Erlanson M, Gustafson P. Kivioja A, Klepp R, Lehtinen T, Lindholm P. Möller T, Ryd-holm A, Saeter G, Trovik C, Wahlström 0, Wiklund T. The Scandinavian Sarcoma Group Register. Acta Orthop Scand 1999; 70: 41–4.
   Google Scholar
• Bern G, Brosjö 0, Jacobsson H. Uptake of Tc-99m MDP in shoulder muscle caused by the use of elbow cruthes. Clun Nucl Med 1999: 691–2.
   Google Scholar
• Bielack S, Schroeders A, Fuch N, Bacci G, Bauer HCF, Tomeno B, Zucchi V, Winkler K. Malignant fibrous histiocytoma (MFH) of bone: Results of a survey of treatment and outcome from EMSOS. Acta Orthop Scand 1999; 70: 353–60.
   PubMed Web of Science ®Google Scholar
• Brosj8 0. Surgical procedure and local recurrence in 223 patients treated 1982–1997 according to two osteosarcoma chemo-therapy protocols. Acta Orthop Scand Suppl 285 1999: 58–61.
   Google Scholar
• Dricu A, Kanter L, Wang M, Nilsson G, Hjertman M, Wejde J, Larsson 0. Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extra-cellural IGF-1 pathway. Glycobiology 1999; 6: 571–9.
   Google Scholar
• Einarsdottir H, Söderlund V, Larson 0, Jenner G, Bauer HCF. Magnetic resonance imaging of lipoma and liposarcoma. Acta Radiol 1999; 40: 64–8.
   Google Scholar
• Einarsdottir H, Soderlund V, Larsson 0, Mandahl N, Bauer H. 110 subfascial lipomatous tumors. MR and CT findings versus histipathological diagnosis and cytogenetic analysis. Acta Radiol 1999; 40: 603–9.
   Google Scholar
• Femberg JO, Brosjo 0, Larsson 0, Söderlund V. Strander H. Interferon-induced remission in aggressive fibromatosis of the lower extremity. Acta Oncol 1999; 38(7): 971–2.
   Google Scholar
• Larramendy ML, Mandahl N, Mertens F, Blomqvist C, Kivioja AH, Karaharju E, Valle J, Böhling T, Tarkkanen M, Rydholm A, Akerman M, Bauer HCF, Elomaa I, Knuutila S. Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas. Hum Pathol 1999; 30: 1247–53.
   Google Scholar
• Meis-Kindblom JM, Bjerkehagen B, Böhling T, Domanski H, Halvorsen TB, Larsson 0, Lilleng P. Myhre-Jensen 0, Sten-wig E, Virolainen, Willen H, Akerman M, Kindblom L-G. Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) register: The peer-review committee experience. Acta Ortoph Scand 1999; 70: 18–26.
   Google Scholar
• Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhl& M, Larsson 0. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 1999; 59: 3180–4.
   Google Scholar
• Nilsson G, Wang M, Wejde J, Kreicbergs A, Larsson 0. Detec-tion of EWS/FLI-1 by immunostaining. An adjunctive tool in diagnosis of Ewing's sarcoma and primitive neuroectodermal tumor on cytological samples and paraffin-embedded archival material. Sarcoma 1999; 3: 25–32.
   Google Scholar
• Saeter G, Wiebe T, Wiklund T, Monge 0, Wahlqvist Y, Engstrom K, Forestier E, Holmstrom T, Stenwiv A, Willén H, Brosjo 0, Follerfis G, Alvegfird T, Strander H. Chemotherapy in osteo-sarcoma. Acta Orthop Scand Suppl 285 1999: 74–82
   PubMedGoogle Scholar
• Skytting B, Bauer H, Larsson 0. Diagnosis, treatment and prog-nosis of patients with synovial sarcoma. Acta Orthop Scand 1999; 70: 47–9.
   PubMed Web of Science ®Google Scholar
• Skytting BT, Bauer HCF, Perfekt R, Huutanen R, Alvegird T, Berling 6, Gustafson P. Klepp R, Lavenborg R, Saeter G, Trovik C, Wahlstrom 0. Clinical course in synovial sarcoma: A Scandinavian sarcoma group study of 104 patients. Acta Orthop Scand 1999; 70: 536–42.
   Google Scholar
• Skytting BT, Bauer HC, Perfekt R, Nilsson G, Larsson 0. Ki-67 is strongly prognostic in synovial sarcoma: analysis based on 86 patients from the Scandinavian Sarcoma Group register. Br J Cancer 1999; 80(11): 1809–14.
   Google Scholar
• Skytting B, lyIeis-Kindblom J, LARSSON 0, Virolainen M, Perfekt R, Akerman M and Kindblom L-G. Synovial sarcoma: Identification of favourable and unfavourable histological types. Histopathological review of 143 synovial sarcoma: A Scandinavian Sarcoma Group study of 104 cases. Acta Orthop Scand 1999; 70: 543–54.
   Google Scholar
• Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlén M, Larsson 0. A novel fusion gene, SYT-SSX4, in synovial sar-coma. J Nail Cancer Inst 1999; 91(11): 974–5.
   Google Scholar
• Skytting B, Szymanska J, Aalto Y, Blomqvist C, Elomaa I, Lars-son 0, Knuutila S. Clinical importance of secondary genetic aberrations in synovial sarcoma evaluated by comparative genomic hybridisation. Cancer Genet Cytogen 1999; 115: 39–46.
   Google Scholar
• Trovik C, Bauer H. Local recurrence after surgery for soft tissue sarcoma. Acta Orthop Scand 1999; 70: 45–6.
   Web of Science ®Google Scholar
• Wang M, Xie Y, Gimita L, Nilsson G, Dricu A, Wejde J, Larsson 0. Regulatory role of mevalonante and n-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells. Exp Cell Res 1999; 246: 38–46.
   Google Scholar
• Wedin R, Bauer HCF, Wersall P. Failures after operation for met-astatic lesions of long bones. Clin Orthop 1999; 358: 128–39.
   Google Scholar
• Xie Y, Skytting B, Nilsson G, Brodin B, Larsson 0. Expression of insulin-like growth factor-1 receptor in synovial sarcoma: Association with an aggressive phenotype. Cancer Res 1999; 59: 3588–91.
   Google Scholar
• Femberg JO, Brosjo 0, Friesland S, Masucci G. GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radio-therapy. Med Oncol 2000; 17: 1–4.
   Google Scholar
• Gimita L, Gimita A, Brodin B, Xie Y, Nilsson G, Dricu A, Lundeberg J, Wejde J, Bartolazzi A, Wiman KG, Larsson 0. Increased expression of insulin-like growth factor 1 receptor in malignant cells expressing aberrant p53: functional impact. Cancer Res 2000; 60(18): 5278–83.
   Google Scholar
• Gimita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson 0. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma. Oncogene 2000; 19: 4298–301.
   Google Scholar
• Gimita L, Wang M, Yuntao X, Nilsson G, Dricu A, Wejde J, Lars-son 0. Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications. Anti-Cancer Drug Design 2000; 15: 67–72.
   Google Scholar
• Mertens F, Larramendy M, Gustavsson A, Gisselson D, Rydholm A, Brosjo 0, Mitelman F, Knuutila S, Mandahl N. Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p. Cancer Genet Cytogenet 2000; 116: 89–96.
   Google Scholar
• Trovik CS, Bauer HCF, Alvegird TA, Anderson H, Blomqvist C, Berlin 6, Gustafson P. Saeter G, Walloe A. Surgical margin, Local recurrence and survival in soft tissue sarcoma. Eur J Cancer 2000; 36: 710–6.
   Google Scholar
• Trovik CS, Gustayson P. Walloe A, Gunterberg B, Blomqvist C, Bauer HCF. Consequences of local recurrence of soft tissue sarcoma. Acta Orthop Scand 2000; 71: 488–95
   PubMed Web of Science ®Google Scholar
• Wedin R, Bauer HCF, Skoog L, Soclerlund V. Tani E. Cytologi-cal diagnosis of skeletal lesions: analysis based on fine needle aspiration biopsy in 110 tumor patients. J Bone Joint Surg Br 2000; 82(5): 673–8.
   Google Scholar
• Bauer HCF, Moller T, Alvegfird TA, Rydholm A, Gustafson P. Solheim 6, Erlanson M, Karlsson M, Monge 0, Trovik C,Blomqvist C, Wiklund T, Berlin 6, Turesson I. Monitoring referral and treatment in soft tissue sarcoma: study based on 1851 patients from the Scandinavian sarcoma group register. Acta Orthop Scand 2001; 72: 150–9.
   Google Scholar
• Bergqvist JE, Brosjo 0. Atraumatisk underbenssmärta medsailsynt genes. Läkartidningen 2001; 36(98): 3804.
   Google Scholar
• Brodin BA, Haslam K, Bartolazzi A, Xie Y, Starborg M, Lunde-berg J, Larsson 0. Cloning and Characterization of SYT/SSX4 and novel splice variants of synovial sarcoma. Gene 2001; 268: 173–82.
   Google Scholar
• Brodin B, Tomkvist M, Haslam K, Xie Y, Bartolazzi A, Larsson 0. A novel fusion gene SYT-55X4 variant in Synovial Sar-coma J Nail Cancer Inst 2001; 93: 1348–9.
   Google Scholar
• Einarsdottir H, Wejde J, Bauer HCF. Preoperative radiotherapy in soft tissue tumors. Assessment of response by static post-con-trast MR imaging compared to histopathology. Acta Radiol 2001; 421: 1–5.
   Google Scholar
• Femberg JO, Brosjo 0, Friesland S, Masucci G. GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radio-therapy. Med Oncol 2001; 18: 231–5.
   Google Scholar
• Lui WO, Weide J, Tani E, Brosjo 0, Kytöld S, Larsson C. A highly aggressive primitive mescenchymal tumor with a translocation t(1;19)(q12;q13.2). Cancer Genet Cytogenet 2001; 127: 128–33.
   Google Scholar
• Mandahl N, Gustafson P. Mertens F, Akerman M, Baldetorp B, Gisselsson D, Knuutila S, Bauer HCF, Larsson 0. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes chromosomes cancer 2001; 33: 188–200.
   Google Scholar
• Panagopoulus I, Mertens F, Domanski HA, Isaksson M, Brosjo 0, Gustafson P. Mandahl N. No EWS/FLI1 fusion transcripts in giant-cell tumors of bone. Int J Cancer 2001; 6: 769–72.
   Google Scholar
• Panagopoulus, Mertens F, Isaksson G, Limon J, Gustafson P. Akerman M, Sciot R, Dal CM P. Samson I, Iliszko M, Ryoe J, Debiec-Rychter M, Szadowska A, Skytting B, Brosjo 0, Bäckdahl M. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 2001; 31: 362–72.
   Google Scholar
• Söderlund V. Tani E, Skoog L, Bauer HCF, Kreicbergs A. Diagnosis of skeletal lymphoma and myeloma by radiology and fine-needle aspiration biopsy. Cytopathology 2001; 12: 157–67.
   Google Scholar
• Trovik CS, Bauer HCF, Berlin 6, Tukiainen E, Erlanson M, Gus-tayson P. Klepp R, Saeter G, Wahlström 0. Local recurrence deep-seated, high-grade, soft tissue sarcoma. Acta Orthop Scand 2001; 72: 160–6.
   Google Scholar
• Ahlen J, Enberg U, Von Rosen A, Frisk T, Larsson C, Larsson 0, Brosjo 0, Bäckdahl M. Malignant fibrous histiocytoma, aggressive fibromatosis and benign fibrous tumors express mRNA for the metallo-proteinase inducer EMMPRIN and the metalloproteinases MMP-2 and MT1-MMP. Sarcoma 2001; 5: 143–9.
   Google Scholar
• Fröstad B, Tani E, Brosjö 0, Skoog L, Kogner P. Fine needle aspiration cytology in the diagnosis and management of chil-dren and adolescents with Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Med Pediatr Oncol 2002; 38: 33–40.
   Google Scholar
• Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldblum JR, Ali SZ, Shipley J, Fisher C, Skytting B, Lars-son 0. Impact of SYT-SSX fusion type on clinical behavior of synovial sarcoma'. A multi-institutional study of 243 patients. Cancer Res 2002; 62: 135–40.
   Google Scholar
• Panagopoulos I, Mertens F, D8biec-Rychter M, Isaksson M, Limon J, Kardas I, Domanski HA, Sciot R, Perek D, Cmalic D, Larsson 0, Mandahl N. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer 2002; 99: 560–7.
   Google Scholar
• Panagopoulus I, Mertens F, Isaksson M, Henryk A, Domanski, Brosj8 0, Sveffe H, Bjerkehagen B, Sciot R, Dal Cin P. Fletcher JA, Fletcher CDM, Mandahl N. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chro-mosomes Cancer 2002; 35: 340–52.
   Google Scholar
• Smeland S, Muller C, Alvegfird TA, Wiklund T, Wiebe T, Bjork 0, Stenwig AE Willen H Holmström T, Folleris G, Brosjo 0, Kivioja A, Jonsson K, Mongo 0, Saeter G. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2002; 39: 488–94.
   Google Scholar
• Soclerlund V, Tani E, Domanski H, Kreicbergs A. Representative-ness of radiologically guided fine-needle aspiration biopsy of bone lesions .Sarcoma 2002; 6: 61–8.
   PubMedGoogle Scholar
• Tönkvist M, Brodin B, Bartolazzi A, Larsson 0. A Novel type of SYT/SSX fusion; Methodological and biological implications. Mod Pathol 2002; 15: 679–85.
   Google Scholar
• Yang K, Lui W-0, Xie Y, Zhang A, Skytting B, Mandahl N, Lars-son C, Larsson 0. Recurrent coexistence of the SYT-SSX1 and SYT-55X2 fusions in synovial sarcomas. Oncogene 2002; 21(98): 4181–90.
   Google Scholar
• Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, Brodin B, Mandahl N, Larsson 0. SYT-SSX fusion gene is critical for expression of cyclin D1 in synovial sarcoma cells. A gain-of-function of t(X;18) (p11.2; q11.2). Cancer Res 2002; 62, 3861–7.
   Google Scholar
• Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham DC, Fisher C, Shipley J, Bjerkehagen B, Myklebost 0, Larsson 0. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and Dl. A link between t(X;18) (p11.2; q11.2) and the cell cycle machinery. Oncogene 2002; 21: 5791–6.
   Google Scholar
• Bauer HCF. Indications for surgical treatment of spinal metasta-ses. Ortopedia, Traumatologia, Rehabilitacja 2003; 5: 164–6.
   PubMedGoogle Scholar
• Dahlén A, Debiec-Rychter M, Pedeutour F, Bauer HCF et al. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 2003; 103: 616–23.
   PubMedGoogle Scholar
• Dahlen A, Mertens F, Rydholm A, Brosjö 0, Wejde J, Mandahl N. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 2003; 16(11): 1132–40.
   Google Scholar
• Einarsdottir H, Bauer HCF, Wejde J, Skoog L, Söderlund V. Dynamic MRI and fine neeclle aspiration cytology in the diagnosis of soft tissue lesions. Skeletal Radiol 2003; 32(12): 695–700.
   Google Scholar
• Grimer RJ, Cannon SR, Taminiau AB, Bauer HCF et al. Oste-osarcoma over the age of forty. Europ J Cancer 2003; 39: 157–63.
   PubMed Web of Science ®Google Scholar
• Lerma E, Tani E, Brosj8 0, Bauer HCF, Söderlund V, Skoog L. Diagnosis and grading of chondrosarcomas on FNA biopsy material. Diagn Cytopathol 2003; 28: 13–7.
   PubMedGoogle Scholar
• Smeland S, Muller C, Alvegfird TA, Wiklund T, Wiebe T, Bjork 0, Stenwig AE, Willen H, Holmstrom T, Folleris G, Brosj8 0, Kivioja A, Jonsson K, Monge 0, Saeter G. Scandinavian sarcoma group osteosarcoma study SSG VIII: prognostic fac-tors for outcome and the role of replacement salvage chemo-therapy for poor histological responders. Eur J Cancer 2003; 39(4): 488–94.
   Google Scholar
• Storlazzi CT, Mertenst F, Nascimento A, Isaksson M, Wejde J, Brosjö 0, Mandahl N, Panagopoulos I. Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. Hum Mol Genet 2003; 12(18): 2349–58.
   Google Scholar
• Wei Y, Sun M, Nilsson G, Dwight T, Xie Y, Wang J, Hou Y, Larsson 0, Larsson C, Thu X. Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas. Oncogene 2003; 22: 2215–22.
   Google Scholar
• Weng WH, Alien J, Lui WO, Brosj8 0, Pang ST, Von Rosen A, Auer G, Larsson 0, Larsson C. Gain of 17q in malignant fibrous histiocytoma is associated with a long disease-free survival and a low risk of developing distant metastatis. Br J Cancer 2003; 89(4): 720–6.
   Google Scholar
• Xie Y, Törnkvist M, Aalto Y, Gimita L, Nilsson G, Knuutila S, Larsson 0. Alteration of gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Onco-gene 2003; 22: 7628–31.
   Google Scholar
• Ahlen J, Weng WW, Brosjö 0, Von Rosen A, Larsson 0, Larsson C. Evaluation of immunohistochemical parameters as prog-nostic markers in malignant fibrous histiocytoma. Oncol Rep 2003; 10(5): 1641–5.
   Google Scholar
• Harden L, Eriksson M, Axelson 0, Flesch-Janys D. Epidemio-logical studies on cancer and exposure to dioxins and related compunds. Dioxins and Health, second edition, edited by Arnold Schecter and Thomas A Gasiewicz 2003.
   Google Scholar
• Hardell L, Hansson Nild K, Sandström M, Carlberg M, Hallquist A, Pihlson A. Vestibular schwannoma, tinnitus and cellular telephones. Neuroepidemiology 2003; 22: 124–9.
   Google Scholar